First Quarter
Financial Supplement
March 31, 2010
1
METLIFE, INC.
TABLE OF CONTENTS
| | | | |
|
HIGHLIGHTS | | | | |
| | | 2 | |
| | | | |
| | | | |
| | | 3 | |
| | | 4 | |
| | | 5 | |
| | | 6 | |
| | | 7 | |
| | | | |
| | | 9 | |
| | | | |
| | | | |
| | | 10 | |
| | | 14 | |
| | | 15 | |
| | | 16 | |
| | | | |
| | | | |
| | | 17 | |
| | | 18 | |
| | | 19 | |
| | | 20 | |
| | | | |
| | | | |
| | | 21 | |
| | | 22 | |
| | | 23 | |
| | | 24 | |
| | | | |
| | | | |
| | | 25 | |
| | | 28 | |
| | | | |
| | | | |
| | | 29 | |
| | | | |
| | | | |
| | | 33 | |
| | | 36 | |
| | | | |
| | | | |
| | | 37 | |
| | | 39 | |
| | | 40 | |
| | | 41 | |
| | | | |
OTHER INFORMATION | | | | |
| | | 42 | |
NOTE:
This Quarterly Financial Supplement (“QFS”) includes certain operating and statistical measures, such as sales and product spreads, among others, to provide supplemental data regarding the performance of our current business. This QFS also includes financial measures, such as operating earnings, operating revenues, operating expenses, operating earnings available to common shareholders and operating earnings available to common shareholders per diluted common share, which do not equate to and should not be viewed as substitutes for generally accepted accounting principles (“GAAP”) net income (loss), GAAP revenues, GAAP expenses, GAAP net income (loss) available to MetLife, Inc.’s common shareholders and GAAP net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share, respectively. Operating earnings is the measure of segment profit or loss we use to evaluate segment performance and allocate resources and, consistent with GAAP accounting guidance for segment reporting, is our measure of segment performance. Operating earnings is also a measure by which MetLife’s senior management’s and other employees’ performance is evaluated for the purposes of determining their compensation under applicable compensation plans.
Operating earnings is defined as operating revenues less operating expenses, net of income tax. Operating earnings available to common shareholders is defined as operating earnings less preferred stock dividends and operating earnings available to common shareholders per diluted common share is calculated by dividing operating earnings available to common shareholders by the number of weighted average diluted common shares outstanding for the period indicated.
Operating revenues is defined as GAAP revenues (i) less net investment gains (losses), (ii) less amortization of unearned revenue related to net investment gains (losses), (iii) plus scheduled periodic settlement payments on derivative instruments that are hedges of investments but do not qualify for hedge accounting treatment, (iv) plus income from discontinued real estate operations and (v) plus, for operating joint ventures reported under the equity method of accounting, the aforementioned adjustments and those identified in the definition of operating expenses, net of income tax, if applicable to these joint ventures.
Operating expenses is defined as GAAP expenses (i) less changes in policyholder benefits associated with asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities, (ii) less costs related to business combinations and noncontrolling interests, (iii) less amortization of deferred acquisition costs (“DAC”) and value of business acquired (“VOBA”) and changes in the policyholder dividend obligation related to net investment gains (losses) and (iv) plus scheduled periodic settlement payments on derivative instruments that are hedges of policyholder account balances but do not qualify for hedge accounting treatment.
In addition, operating revenues and operating expenses do not reflect the consolidation of certain securitization vehicles that are variable interest entities as required under GAAP.
MetLife believes the presentation of operating earnings as we measure it for management purposes enhances the understanding of its performance by highlighting the results from operations and the underlying profitability drivers of the business. Reconciliations of operating earnings to GAAP net income (loss) from continuing operations, net of income tax, operating earnings available to common shareholders to GAAP net income (loss) available to MetLife, Inc.’s common shareholders and operating earnings available to common shareholders per diluted common share to GAAP net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share, the most directly comparable GAAP measures, are included in the QFS and in MetLife’s earnings press release dated April 29, 2010, for the three months ended March 31, 2010, which are available at www.metlife.com.
1
METLIFE, INC.
CORPORATE OVERVIEW
| | | | | | | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions, except per share data) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings available to common shareholders | | | $ | 131 | | | $ | 723 | | | $ | 718 | | | $ | 793 | | | | $ | 834 | | |
Preferred stock dividends | | | | 30 | | | | 31 | | | | 30 | | | | 31 | | | | | 30 | | |
| | | | | | | |
Operating earnings | | | | 161 | | | | 754 | | | | 748 | | | | 824 | | | | | 864 | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | (906 | ) | | | (3,829 | ) | | | (2,139 | ) | | | (898 | ) | | | | 72 | | |
Other adjustments to continuing operations | | | | (241 | ) | | | 473 | | | | 46 | | | | 6 | | | | | (121 | ) | |
Provision for income tax expense (benefit) | | | | 401 | | | | 1,183 | | | | 721 | | | | 378 | | | | | 18 | | |
| | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | (585 | ) | | | (1,419 | ) | | | (624 | ) | | | 310 | | | | | 833 | | |
Income (loss) from discontinued operations, net of income tax | | | | 37 | | | | 1 | | | | (1 | ) | | | 3 | | | | | 1 | | |
| | | | | | | |
Net income (loss) | | | | (548 | ) | | | (1,418 | ) | | | (625 | ) | | | 313 | | | | | 834 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | (4 | ) | | | (16 | ) | | | (5 | ) | | | (7 | ) | | | | (1 | ) | |
| | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | (544 | ) | | | (1,402 | ) | | | (620 | ) | | | 320 | | | | | 835 | | |
Less: Preferred stock dividends | | | | 30 | | | | 31 | | | | 30 | | | | 31 | | | | | 30 | | |
| | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | (574 | ) | | $ | (1,433 | ) | | $ | (650 | ) | | $ | 289 | | | | $ | 805 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings available to common shareholders — diluted | | | $ | 0.16 | | | $ | 0.88 | | | $ | 0.87 | | | $ | 0.96 | | | | $ | 1.01 | | |
Net investment gains (losses) | | | | (1.12 | ) | | | (4.64 | ) | | | (2.59 | ) | | | (1.08 | ) | | | | 0.09 | | |
Other adjustments to continuing operations | | | | (0.30 | ) | | | 0.57 | | | | 0.06 | | | | 0.01 | | | | | (0.15 | ) | |
Provision for income tax expense (benefit) | | | | 0.50 | | | | 1.43 | | | | 0.86 | | | | 0.45 | | | | | 0.02 | | |
Discontinued operations, net of income tax | | | | 0.05 | | | | — | | | | — | | | | — | | | | | — | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | — | | | | (0.02 | ) | | | (0.01 | ) | | | (0.01 | ) | | | | — | | |
| | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders per common share — diluted | | | $ | (0.71 | ) | | $ | (1.74 | ) | | $ | (0.79 | ) | | $ | 0.35 | | | | $ | 0.97 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Weighted average common shares outstanding — diluted | | | | 810.8 | | | | 825.1 | | | | 827.3 | | | | 828.0 | | | | | 828.6 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Book value per common share — (actual common shares outstanding) | | | $ | 25.75 | | | $ | 30.85 | | | $ | 39.36 | | | $ | 37.96 | | | | $ | 41.21 | | |
Book value per common share, excluding accumulated other comprehensive income (loss) — (actual common shares outstanding) | | | $ | 44.53 | | | $ | 42.86 | | | $ | 42.09 | | | $ | 41.69 | | | | $ | 42.67 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Book value per common share — diluted — (weighted average common shares outstanding) | | | $ | 25.98 | | | $ | 30.60 | | | $ | 38.95 | | | $ | 37.54 | | | | $ | 40.75 | | |
Book value per common share, excluding accumulated other comprehensive income (loss) — diluted — (weighted average common shares outstanding) | | | $ | 44.93 | | | $ | 42.52 | | | $ | 41.65 | | | $ | 41.23 | | | | $ | 42.19 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Common shares outstanding, beginning of period | | | | 793.6 | | | | 818.1 | | | | 818.6 | | | | 818.8 | | | | | 818.8 | | |
Treasury stock, net | | | | 0.1 | | | | 0.5 | | | | 0.2 | | | | — | | | | | 0.3 | | |
Newly issued shares | | | | 24.4 | | | | — | | | | — | | | | — | | | | | 0.3 | | |
| | | | | | | |
Common shares outstanding, end of period | | | | 818.1 | | | | 818.6 | | | | 818.8 | | | | 818.8 | | | | | 819.4 | | |
| | | | | | | |
| | | | | | �� | | | | | | | | | | | | | | | | | |
Weighted average common shares outstanding — basic | | | | 809.1 | | | | 821.6 | | | | 821.8 | | | | 821.9 | | | | | 822.6 | | |
Dilutive effect of stock-based awards | | | | 1.7 | | | | 3.5 | | | | 5.5 | | | | 6.1 | | | | | 6.0 | | |
| | | | | | | |
Weighted average common shares outstanding — diluted | | | | 810.8 | | | | 825.1 | | | | 827.3 | | | | 828.0 | | | | | 828.6 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Policyholder Trust Shares | | | | 240.8 | | | | 238.7 | | | | 236.8 | | | | 233.2 | | | | | 229.9 | | |
| | | | | | | |
2
METLIFE, INC.
CONSOLIDATED BALANCE SHEETS
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
ASSETS | | | | | | | | | | | | | | | | | | | | | | | |
Investments: | | | | | | | | | | | | | | | | | | | | | | | |
Fixed maturity securities available-for-sale, at estimated fair value | | | $ | 191,415 | | | $ | 211,563 | | | $ | 223,896 | | | $ | 227,642 | | | | $ | 239,566 | | |
Equity securities available-for-sale, at estimated fair value | | | | 2,817 | | | | 3,045 | | | | 3,117 | | | | 3,084 | | | | | 3,066 | | |
Trading securities, at estimated fair value (1) | | | | 922 | | | | 1,471 | | | | 1,970 | | | | 2,384 | | | | | 3,039 | | |
Mortgage loans: | | | | | | | | | | | | | | | | | | | | | | | |
Held-for-investment, at amortized cost | | | | 49,074 | | | | 48,229 | | | | 48,239 | | | | 48,181 | | | | | 48,368 | | |
Held-for-sale, principally at estimated fair value | | | | 3,970 | | | | 4,271 | | | | 2,442 | | | | 2,728 | | | | | 2,003 | | |
Held by consolidated securitization entities, at estimated fair value | | | | — | | | | — | | | | — | | | | — | | | | | 7,065 | | |
| | | | | | | |
Mortgage loans, net | | | | 53,044 | | | | 52,500 | | | | 50,681 | | | | 50,909 | | | | | 57,436 | | |
Policy loans | | | | 9,851 | | | | 9,907 | | | | 10,001 | | | | 10,061 | | | | | 10,146 | | |
Real estate and real estate joint ventures | | | | 7,331 | | | | 7,246 | | | | 6,982 | | | | 6,852 | | | | | 6,826 | | |
Real estate held-for-sale | | | | 50 | | | | 50 | | | | 50 | | | | 44 | | | | | 40 | | |
Other limited partnership interests | | | | 5,365 | | | | 5,193 | | | | 5,255 | | | | 5,508 | | | | | 5,753 | | |
Short-term investments | | | | 10,896 | | | | 8,117 | | | | 6,861 | | | | 8,374 | | | | | 8,019 | | |
Other invested assets | | | | 15,130 | | | | 13,071 | | | | 13,916 | | | | 12,709 | | | | | 12,327 | | |
| | | | | | | |
Total investments | | | | 296,821 | | | | 312,163 | | | | 322,729 | | | | 327,567 | | | | | 346,218 | | |
Cash and cash equivalents (1) | | | | 19,424 | | | | 13,213 | | | | 15,562 | | | | 10,112 | | | | | 9,202 | | |
Accrued investment income | | | | 3,142 | | | | 3,019 | | | | 3,236 | | | | 3,173 | | | | | 3,392 | | |
Premiums and other receivables | | | | 18,514 | | | | 16,730 | | | | 16,903 | | | | 16,752 | | | | | 17,554 | | |
Deferred policy acquisition costs and value of business acquired | | | | 20,754 | | | | 20,323 | | | | 19,208 | | | | 19,256 | | | | | 18,697 | | |
Current income tax recoverable | | | | — | | | | 253 | | | | 412 | | | | 316 | | | | | — | | |
Deferred income tax assets | | | | 6,349 | | | | 3,856 | | | | 535 | | | | 1,228 | | | | | 149 | | |
Goodwill | | | | 5,010 | | | | 5,036 | | | | 5,033 | | | | 5,047 | | | | | 5,049 | | |
Other assets | | | | 7,028 | | | | 7,896 | | | | 7,140 | | | | 6,822 | | | | | 6,869 | | |
Separate account assets | | | | 114,366 | | | | 126,968 | | | | 144,434 | | | | 149,041 | | | | | 158,436 | | |
| | | | | | | |
Total assets | | | $ | 491,408 | | | $ | 509,457 | | | $ | 535,192 | | | $ | 539,314 | | | | $ | 565,566 | | |
| | | | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | | | | | | | | | | | |
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | |
Future policy benefits | | | $ | 131,609 | | | $ | 132,823 | | | $ | 134,492 | | | $ | 135,879 | | | | $ | 137,516 | | |
Policyholder account balances | | | | 141,037 | | | | 140,076 | | | | 139,171 | | | | 138,673 | | | | | 141,734 | | |
Other policyholder funds | | | | 8,136 | | | | 8,319 | | | | 8,549 | | | | 8,446 | | | | | 8,682 | | |
Policyholder dividends payable | | | | 846 | | | | 881 | | | | 911 | | | | 761 | | | | | 745 | | |
Payables for collateral under securities loaned and other transactions | | | | 24,341 | | | | 24,607 | | | | 24,363 | | | | 24,196 | | | | | 25,982 | | |
Bank deposits | | | | 7,531 | | | | 7,807 | | | | 8,372 | | | | 10,211 | | | | | 10,032 | | |
Short-term debt | | | | 5,878 | | | | 4,757 | | | | 2,131 | | | | 912 | | | | | 318 | | |
Long-term debt (1) | | | | 11,042 | | | | 12,940 | | | | 13,202 | | | | 13,220 | | | | | 20,177 | | |
Collateral financing arrangements | | | | 5,242 | | | | 5,297 | | | | 5,297 | | | | 5,297 | | | | | 5,297 | | |
Junior subordinated debt securities | | | | 2,691 | | | | 2,691 | | | | 3,191 | | | | 3,191 | | | | | 3,191 | | |
Current income tax payable | | | | 635 | | | | — | | | | — | | | | — | | | | | 66 | | |
Other liabilities | | | | 14,625 | | | | 14,679 | | | | 16,486 | | | | 15,989 | | | | | 17,211 | | |
Separate account liabilities | | | | 114,366 | | | | 126,968 | | | | 144,434 | | | | 149,041 | | | | | 158,436 | | |
| | | | | | | |
Total liabilities | | | | 467,979 | | | | 481,845 | | | | 500,599 | | | | 505,816 | | | | | 529,387 | | |
| | | | | | | |
Stockholders’ Equity | | | | | | | | | | | | | | | | | | | | | | | |
Preferred stock, at par value | | | | 1 | | | | 1 | | | | 1 | | | | 1 | | | | | 1 | | |
Common stock, at par value | | | | 8 | | | | 8 | | | | 8 | | | | 8 | | | | | 8 | | |
Additional paid-in capital | | | | 16,860 | | | | 16,849 | | | | 16,865 | | | | 16,859 | | | | | 16,871 | | |
Retained earnings | | | | 21,829 | | | | 20,472 | | | | 19,822 | | | | 19,501 | | | | | 20,294 | | |
Treasury stock, at cost | | | | (230 | ) | | | (203 | ) | | | (194 | ) | | | (190 | ) | | | | (172 | ) | |
Accumulated other comprehensive loss | | | | (15,358 | ) | | | (9,834 | ) | | | (2,234 | ) | | | (3,058 | ) | | | | (1,191 | ) | |
| | | | | | | |
Total MetLife, Inc.’s stockholders’ equity | | | | 23,110 | | | | 27,293 | | | | 34,268 | | | | 33,121 | | | | | 35,811 | | |
Noncontrolling interests | | | | 319 | | | | 319 | | | | 325 | | | | 377 | | | | | 368 | | |
| | | | | | | |
Total equity | | | | 23,429 | | | | 27,612 | | | | 34,593 | | | | 33,498 | | | | | 36,179 | | |
| | | | | | | |
Total liabilities and stockholders’ equity | | | $ | 491,408 | | | $ | 509,457 | | | $ | 535,192 | | | $ | 539,314 | | | | $ | 565,566 | | |
| | | | | | | |
(1) | | Effective January 1, 2010, balances include the effect of consolidating under GAAP certain variable interest entities that are treated as consolidated securitization entities which reflect, at estimated fair value, $274 million of trading securities, $38 million of cash and cash equivalents and $7,106 million of long-term debt at March 31, 2010. |
3
METLIFE, INC.
CONSOLIDATED STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | |
| | | For the Three Months Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 6,122 | | | $ | 6,576 | | | $ | 6,601 | | | $ | 7,161 | | | | $ | 6,854 | | |
Universal life and investment-type product policy fees | | | | 1,189 | | | | 1,227 | | | | 1,255 | | | | 1,559 | | | | | 1,408 | | |
Net investment income | | | | 3,274 | | | | 3,859 | | | | 3,956 | | | | 4,000 | | | | | 4,293 | | |
Other revenues | | | | 554 | | | | 572 | | | | 602 | | | | 601 | | | | | 513 | | |
| | | | | | | |
Total operating revenues | | | | 11,139 | | | | 12,234 | | | | 12,414 | | | | 13,321 | | | | | 13,068 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | 6,979 | | | | 7,388 | | | | 7,549 | | | | 7,986 | | | | | 7,890 | | |
Interest credited to policyholder account balances | | | | 1,170 | | | | 1,229 | | | | 1,259 | | | | 1,195 | | | | | 1,146 | | |
Interest credited to bank deposits | | | | 43 | | | | 40 | | | | 37 | | | | 43 | | | | | 39 | | |
Capitalization of DAC | | | | (786 | ) | | | (757 | ) | | | (722 | ) | | | (754 | ) | | | | (744 | ) | |
Amortization of DAC and VOBA | | | | 746 | | | | 332 | | | | 376 | | | | 564 | | | | | 588 | | |
Interest expense | | | | 245 | | | | 256 | | | | 274 | | | | 269 | | | | | 264 | | |
Other expenses | | | | 2,557 | | | | 2,765 | | | | 2,723 | | | | 2,947 | | | | | 2,645 | | |
| | | | | | | |
Total operating expenses | | | | 10,954 | | | | 11,253 | | | | 11,496 | | | | 12,250 | | | | | 11,828 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 185 | | | | 981 | | | | 918 | | | | 1,071 | | | | | 1,240 | | |
Provision for income tax expense (benefit) | | | | 24 | | | | 227 | | | | 170 | | | | 247 | | | | | 376 | | |
| | | | | | | |
Operating earnings | | | | 161 | | | | 754 | | | | 748 | | | | 824 | | | | | 864 | | |
Preferred stock dividends | | | | 30 | | | | 31 | | | | 30 | | | | 31 | | | | | 30 | | |
| | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 131 | | | $ | 723 | | | $ | 718 | | | $ | 793 | | | | $ | 834 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 161 | | | $ | 754 | | | $ | 748 | | | $ | 824 | | | | $ | 864 | | |
| | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | (906 | ) | | | (3,829 | ) | | | (2,139 | ) | | | (898 | ) | | | | 72 | | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | (6 | ) | | | (11 | ) | | | (4 | ) | | | (6 | ) | | | | (1 | ) | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | (31 | ) | | | (32 | ) | | | 4 | | | | (29 | ) | | | | (49 | ) | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | 20 | | | | (96 | ) | | | (35 | ) | | | (45 | ) | | | | (5 | ) | |
Real estate discontinued operations | | | | (2 | ) | | | (1 | ) | | | (2 | ) | | | (2 | ) | | | | (1 | ) | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | 106 | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | (11 | ) | | | — | | | | — | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | (16 | ) | | | 8 | | | | (63 | ) | | | (2 | ) | | | | (24 | ) | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | 2 | | | | — | | | | 1 | | | | 1 | | | | | 3 | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | (183 | ) | | | 625 | | | | 174 | | | | 95 | | | | | (14 | ) | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | (106 | ) | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | (3 | ) | | | (20 | ) | | | (7 | ) | | | (8 | ) | | | | (1 | ) | |
Business combination costs | | | | (11 | ) | | | — | | | | (22 | ) | | | 2 | | | | | (29 | ) | |
Provision for income tax expense (benefit) | | | | 401 | | | | 1,183 | | | | 721 | | | | 378 | | | | | 18 | | |
| | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | (585 | ) | | | (1,419 | ) | | | (624 | ) | | | 310 | | | | | 833 | | |
Income (loss) from discontinued operations, net of income tax | | | | 37 | | | | 1 | | | | (1 | ) | | | 3 | | | | | 1 | | |
| | | | | | | |
Net income (loss) | | | | (548 | ) | | | (1,418 | ) | | | (625 | ) | | | 313 | | | | | 834 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | (4 | ) | | | (16 | ) | | | (5 | ) | | | (7 | ) | | | | (1 | ) | |
| | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | (544 | ) | | | (1,402 | ) | | | (620 | ) | | | 320 | | | | | 835 | | |
Less: Preferred stock dividends | | | | 30 | | | | 31 | | | | 30 | | | | 31 | | | | | 30 | | |
| | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | (574 | ) | | $ | (1,433 | ) | | $ | (650 | ) | | $ | 289 | | | | $ | 805 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 7,865 | | | $ | 8,375 | | | $ | 8,458 | | | $ | 9,321 | | | | $ | 8,775 | | |
| | | | | | | |
4
METLIFE, INC.
CONSOLIDATING BALANCE SHEET
| | | | | | | | | | | | | | | | | | | |
| | | | |
| | | March 31, 2010 | |
| | | | | | | | | | | | | | | | Banking, | |
Unaudited (In millions) | | | Consolidated | | | U.S. Business | | International | | Corporate & Other (1) | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | |
ASSETS | | | | | | | | | | | | | | | | | | | |
Total investments (1) | | | $ | 346,218 | | | | $ | 272,476 | | | $ | 21,322 | | | $ | 52,420 | | |
Cash and cash equivalents (1) | | | | 9,202 | | | | | 2,138 | | | | 1,457 | | | | 5,607 | | |
Accrued investment income | | | | 3,392 | | | | | 2,666 | | | | 312 | | | | 414 | | |
Premiums and other receivables | | | | 17,554 | | | | | 10,001 | | | | 913 | | | | 6,640 | | |
Deferred policy acquisition costs and value of business acquired | | | | 18,697 | | | | | 15,684 | | | | 3,009 | | | | 4 | | |
Current income tax recoverable | | | | — | | | | | — | | | | — | | | | — | | |
Deferred income tax assets | | | | 149 | | | | | (138 | ) | | | 58 | | | | 229 | | |
Goodwill | | | | 5,049 | | | | | 4,163 | | | | 416 | | | | 470 | | |
Other assets | | | | 6,869 | | | | | 4,298 | | | | 500 | | | | 2,071 | | |
Separate account assets | | | | 158,436 | | | | | 150,516 | | | | 7,920 | | | | — | | |
| | | | | | | |
Total assets | | | $ | 565,566 | | | | $ | 461,804 | | | $ | 35,907 | | | $ | 67,855 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | | | | | | | |
Liabilities: | | | | | | | | | | | | | | | | | | | |
Future policy benefits | | | $ | 137,516 | | | | $ | 120,727 | | | $ | 11,274 | | | $ | 5,515 | | |
Policyholder account balances | | | | 141,734 | | | | | 132,946 | | | | 8,740 | | | | 48 | | |
Other policyholder funds | | | | 8,682 | | | | | 6,525 | | | | 1,759 | | | | 398 | | |
Policyholder dividends payable | | | | 745 | | | | | 745 | | | | — | | | | — | | |
Payables for collateral under securities loaned and other transactions | | | | 25,982 | | | | | 17,985 | | | | 13 | | | | 7,984 | | |
Bank deposits | | | | 10,032 | | | | | — | | | | — | | | | 10,032 | | |
Short-term debt | | | | 318 | | | | | — | | | | 14 | | | | 304 | | |
Long-term debt (1) | | | | 20,177 | | | | | 104 | | | | 6 | | | | 20,067 | | |
Collateral financing arrangements | | | | 5,297 | | | | | — | | | | — | | | | 5,297 | | |
Junior subordinated debt securities | | | | 3,191 | | | | | — | | | | — | | | | 3,191 | | |
Current income tax payable | | | | 66 | | | | | (14 | ) | | | (124 | ) | | | 204 | | |
Other liabilities | | | | 17,211 | | | | | 9,950 | | | | 1,379 | | | | 5,882 | | |
Separate account liabilities | | | | 158,436 | | | | | 150,516 | | | | 7,920 | | | | — | | |
| | | | | | | |
Total liabilities | | | | 529,387 | | | | | 439,484 | | | | 30,981 | | | | 58,922 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Stockholders’ Equity | | | | | | | | | | | | | | | | | | | |
Preferred stock, at par value | | | | 1 | | | | | — | | | | — | | | | 1 | | |
Common stock, at par value | | | | 8 | | | | | — | | | | — | | | | 8 | | |
Allocated equity (2) | | | | 37,165 | | | | | 23,657 | | | | 4,301 | | | | 9,207 | | |
Treasury stock | | | | (172 | ) | | | | — | | | | — | | | | (172 | ) | |
Accumulated other comprehensive income (loss) | | | | (1,191 | ) | | | | (1,334 | ) | | | 418 | | | | (275 | ) | |
| | | | | | | |
Total MetLife, Inc.’s stockholders’ equity | | | | 35,811 | | | | | 22,323 | | | | 4,719 | | | | 8,769 | | |
| | | | | | | |
Noncontrolling interests | | | | 368 | | | | | (3 | ) | | | 207 | | | | 164 | | |
| | | | | | | |
Total equity | | | | 36,179 | | | | | 22,320 | | | | 4,926 | | | | 8,933 | | |
| | | | | | | |
Total liabilities and stockholders’ equity | | | $ | 565,566 | | | | $ | 461,804 | | | $ | 35,907 | | | $ | 67,855 | | |
| | | | | | | |
(1) | | Includes the effect of consolidating under GAAP certain variable interest entities that are treated as consolidated securitization entities which reflect, at estimated fair value, $7,339 million in total investments, $38 million in cash and cash equivalents and $7,106 million of long-term debt at March 31, 2010. |
|
(2) | | Allocated equity includes additional paid-in capital and retained earnings. |
5
METLIFE, INC.
CONSOLIDATING BALANCE SHEET — U.S. BUSINESS
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | |
| | | March 31, 2010 | |
| | | | | | | | Insurance | | Retirement | | Corporate Benefit | | | |
Unaudited (In millions) | | | U.S. Business | | | Products | | Products | | Funding | | Auto & Home | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
ASSETS | | | | | | | | | | | | | | | | | | | | | | | |
Total investments | | | $ | 272,476 | | | | $ | 105,701 | | | $ | 52,332 | | | $ | 110,613 | | | $ | 3,830 | | |
Cash and cash equivalents | | | | 2,138 | | | | | 459 | | | | 31 | | | | 1,613 | | | | 35 | | |
Accrued investment income | | | | 2,666 | | | | | 1,121 | | | | 518 | | | | 971 | | | | 56 | | |
Premiums and other receivables | | | | 10,001 | | | | | 6,298 | | | | 568 | | | | 2,152 | | | | 983 | | |
Deferred policy acquisition costs and value of business acquired | | | | 15,684 | | | | | 9,522 | | | | 5,906 | | | | 78 | | | | 178 | | |
Current income tax recoverable | | | | — | | | | | — | | | | — | | | | — | | | | — | | |
Deferred income tax assets | | | | (138 | ) | | | | (1,785 | ) | | | (931 | ) | | | 2,491 | | | | 87 | | |
Goodwill | | | | 4,163 | | | | | 1,414 | | | | 1,692 | | | | 900 | | | | 157 | | |
Other assets | | | | 4,298 | | | | | 1,900 | | | | 1,633 | | | | 411 | | | | 354 | | |
Separate account assets | | | | 150,516 | | | | | 9,132 | | | | 92,554 | | | | 48,830 | | | | — | | |
| | | | | | | |
Total assets | | | $ | 461,804 | | | | $ | 133,762 | | | $ | 154,303 | | | $ | 168,059 | | | $ | 5,680 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | | | | | | | | | | | |
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | |
Future policy benefits | | | $ | 120,727 | | | | $ | 71,321 | | | $ | 4,071 | | | $ | 42,354 | | | $ | 2,981 | | |
Policyholder account balances | | | | 132,946 | | | | | 28,621 | | | | 46,492 | | | | 57,833 | | | | — | | |
Other policyholder funds | | | | 6,525 | | | | | 5,984 | | | | 105 | | | | 267 | | | | 169 | | |
Policyholder dividends payable | | | | 745 | | | | | 745 | | | | — | | | | — | | | | — | | |
Payables for collateral under securities loaned and other transactions | | | | 17,985 | | | | | 4,133 | | | | 3,482 | | | | 10,370 | | | | — | | |
Bank deposits | | | | — | | | | | — | | | | — | | | | — | | | | — | | |
Short-term debt | | | | — | | | | | — | | | | — | | | | — | | | | — | | |
Long-term debt | | | | 104 | | | | | (75 | ) | | | 8 | | | | 171 | | | | — | | |
Collateral financing arrangements | | | | — | | | | | — | | | | — | | | | — | | | | — | | |
Junior subordinated debt securities | | | | — | | | | | — | | | | — | | | | — | | | | — | | |
Current income tax payable | | | | (14 | ) | | | | (301 | ) | | | 305 | | | | (25 | ) | | | 7 | | |
Other liabilities | | | | 9,950 | | | | | 5,641 | | | | 1,057 | | | | 2,534 | | | | 718 | | |
Separate account liabilities | | | | 150,516 | | | | | 9,132 | | | | 92,554 | | | | 48,830 | | | | — | | |
| | | | | | | |
Total liabilities | | | | 439,484 | | | | | 125,201 | | | | 148,074 | | | | 162,334 | | | | 3,875 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Stockholders’ Equity | | | | | | | | | | | | | | | | | | | | | | | |
Preferred stock, at par value | | | | — | | | | | — | | | | — | | | | — | | | | — | | |
Common stock, at par value | | | | — | | | | | — | | | | — | | | | — | | | | — | | |
Allocated equity (1) | | | | 23,657 | | | | | 9,233 | | | | 6,219 | | | | 6,372 | | | | 1,833 | | |
Treasury stock, at cost | | | | — | | | | | — | | | | — | | | | — | | | | — | | |
Accumulated other comprehensive loss | | | | (1,334 | ) | | | | (672 | ) | | | 10 | | | | (644 | ) | | | (28 | ) | |
| | | | | | | |
Total MetLife, Inc.’s stockholders’ equity | | | | 22,323 | | | | | 8,561 | | | | 6,229 | | | | 5,728 | | | | 1,805 | | |
| | | | | | | |
Noncontrolling interests | | | | (3 | ) | | | | — | | | | — | | | | (3 | ) | | | — | | |
| | | | | | | |
Total equity | | | | 22,320 | | | | | 8,561 | | | | 6,229 | | | | 5,725 | | | | 1,805 | | |
| | | | | | | |
Total liabilities and stockholders’ equity | | | $ | 461,804 | | | | $ | 133,762 | | | $ | 154,303 | | | $ | 168,059 | | | $ | 5,680 | | |
| | | | | | | |
(1) | | Allocated equity includes additional paid-in capital and retained earnings. |
6
METLIFE, INC.
CONSOLIDATING STATEMENT OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended March 31, 2010 | |
| | | | | | | | | | | | | | | | Banking, | |
Unaudited (In millions) | | | Consolidated | | | U.S. Business | | International | | Corporate & Other | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 6,854 | | | | $ | 5,961 | | | $ | 893 | | | $ | — | | |
Universal life and investment-type product policy fees | | | | 1,408 | | | | | 1,117 | | | | 291 | | | | — | | |
Net investment income | | | | 4,293 | | | | | 3,600 | | | | 450 | | | | 243 | | |
Other revenues | | | | 513 | | | | | 299 | | | | 1 | | | | 213 | | |
| | | | | | | |
Total operating revenues | | | | 13,068 | | | | | 10,977 | | | | 1,635 | | | | 456 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | 7,890 | | | | | 7,057 | | | | 838 | | | | (5 | ) | |
Interest credited to policyholder account balances | | | | 1,146 | | | | | 995 | | | | 151 | | | | — | | |
Interest credited to bank deposits | | | | 39 | | | | | — | | | | — | | | | 39 | | |
Capitalization of DAC | | | | (744 | ) | | | | (552 | ) | | | (192 | ) | | | — | | |
Amortization of DAC and VOBA | | | | 588 | | | | | 483 | | | | 105 | | | | — | | |
Interest expense | | | | 264 | | | | | 2 | | | | 1 | | | | 261 | | |
Other expenses | | | | 2,645 | | | | | 1,849 | | | | 522 | | | | 274 | | |
| | | | | | | |
Total operating expenses | | | | 11,828 | | | | | 9,834 | | | | 1,425 | | | | 569 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 1,240 | | | | | 1,143 | | | | 210 | | | | (113 | ) | |
Provision for income tax expense (benefit) | | | | 376 | | | | | 386 | | | | 59 | | | | (69 | ) | |
| | | | | | | |
Operating earnings | | | | 864 | | | | | 757 | | | | 151 | | | | (44 | ) | |
Preferred stock dividends | | | | 30 | | | | | — | | | | — | | | | 30 | | |
| | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 834 | | | | $ | 757 | | | $ | 151 | | | $ | (74 | ) | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 864 | | | | $ | 757 | | | $ | 151 | | | $ | (44 | ) | |
| | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | 72 | | | | | 128 | | | | (29 | ) | | | (27 | ) | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | (1 | ) | | | | (1 | ) | | | — | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | (49 | ) | | | | (49 | ) | | | (8 | ) | | | 8 | | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | (5 | ) | | | | — | | | | (5 | ) | | | — | | |
Real estate discontinued operations | | | | (1 | ) | | | | (1 | ) | | | — | | | | — | | |
Net investment income related to consolidated securitization entities | | | | 106 | | | | | — | | | | — | | | | 106 | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | | — | | | | — | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | (24 | ) | | | | (5 | ) | | | (19 | ) | | | — | | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | 3 | | | | | 3 | | | | — | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | (14 | ) | | | | (14 | ) | | | — | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | (106 | ) | | | | — | | | | — | | | | (106 | ) | |
Other expenses: | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | (1 | ) | | | | 1 | | | | (3 | ) | | | 1 | | |
Business combination costs | | | | (29 | ) | | | | — | | | | — | | | | (29 | ) | |
Provision for income tax expense (benefit) | | | | 18 | | | | | (23 | ) | | | 24 | | | | 17 | | |
| | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | 833 | | | | | 796 | | | | 111 | | | | (74 | ) | |
Income (loss) from discontinued operations, net of income tax | | | | 1 | | | | | 1 | | | | — | | | | — | | |
| | | | | | | |
Net income (loss) | | | | 834 | | | | | 797 | | | | 111 | | | | (74 | ) | |
Less: Net income (loss) attributable to noncontrolling interest | | | | (1 | ) | | | | — | | | | (2 | ) | | | 1 | | |
| | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | 835 | | | | | 797 | | | | 113 | | | | (75 | ) | |
Less: Preferred stock dividends | | | | 30 | | | | | — | | | | — | | | | 30 | | |
| | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | 805 | | | | $ | 797 | | | $ | 113 | | | $ | (105 | ) | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 8,775 | | | | $ | 7,377 | | | $ | 1,185 | | | $ | 213 | | |
| | | | | | | |
7
METLIFE, INC.
CONSOLIDATING STATEMENT OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended March 31, 2009 | |
| | | | | | | | | | | | | | | | Banking, | |
Unaudited (In millions) | | | Consolidated | | | U.S. Business | | International | | Corporate & Other | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 6,122 | | | | $ | 5,399 | | | $ | 721 | | | $ | 2 | | |
Universal life and investment-type product policy fees | | | | 1,189 | | | | | 979 | | | | 210 | | | | — | | |
Net investment income | | | | 3,274 | | | | | 3,055 | | | | 168 | | | | 51 | | |
Other revenues | | | | 554 | | | | | 285 | | | | 2 | | | | 267 | | |
| | | | | | | |
Total operating revenues | | | | 11,139 | | | | | 9,718 | | | | 1,101 | | | | 320 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | 6,979 | | | | | 6,431 | | | | 548 | | | | — | | |
Interest credited to policyholder account balances | | | | 1,170 | | | | | 1,092 | | | | 78 | | | | — | | |
Interest credited to bank deposits | | | | 43 | | | | | — | | | | — | | | | 43 | | |
Capitalization of DAC | | | | (786 | ) | | | | (641 | ) | | | (145 | ) | | | — | | |
Amortization of DAC and VOBA | | | | 746 | | | | | 651 | | | | 95 | | | | — | | |
Interest expense | | | | 245 | | | | | 3 | | | | 2 | | | | 240 | | |
Other expenses | | | | 2,557 | | | | | 1,934 | | | | 336 | | | | 287 | | |
| | | | | | | |
Total operating expenses | | | | 10,954 | | | | | 9,470 | | | | 914 | | | | 570 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 185 | | | | | 248 | | | | 187 | | | | (250 | ) | |
Provision for income tax expense (benefit) | | | | 24 | | | | | 70 | | | | 56 | | | | (102 | ) | |
| | | | | | | |
Operating earnings | | | | 161 | | | | | 178 | | | | 131 | | | | (148 | ) | |
Preferred stock dividends | | | | 30 | | | | | — | | | | — | | | | 30 | | |
| | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 131 | | | | $ | 178 | | | $ | 131 | | | $ | (178 | ) | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 161 | | | | $ | 178 | | | $ | 131 | | | $ | (148 | ) | |
| | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | (906 | ) | | | | (1,664 | ) | | | 454 | | | | 304 | | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | (6 | ) | | | | (6 | ) | | | — | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | (31 | ) | | | | (35 | ) | | | 5 | | | | (1 | ) | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | 20 | | | | | — | | | | 20 | | | | — | | |
Real estate discontinued operations | | | | (2 | ) | | | | (2 | ) | | | — | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | | — | | | | — | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | (11 | ) | | | | (11 | ) | | | — | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | (16 | ) | | | | 6 | | | | (22 | ) | | | — | | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | 2 | | | | | 1 | | | | 1 | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | (183 | ) | | | | (183 | ) | | | — | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | | — | | | | — | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | (3 | ) | | | | — | | | | (5 | ) | | | 2 | | |
Business combination costs | | | | (11 | ) | | | | — | | | | — | | | | (11 | ) | |
Provision for income tax expense (benefit) | | | | 401 | | | | | 658 | | | | (149 | ) | | | (108 | ) | |
| | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | (585 | ) | | | | (1,058 | ) | | | 435 | | | | 38 | | |
Income (loss) from discontinued operations, net of income tax | | | | 37 | | | | | 25 | | | | — | | | | 12 | | |
| | | | | | | |
Net income (loss) | | | | (548 | ) | | | | (1,033 | ) | | | 435 | | | | 50 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | (4 | ) | | | | — | | | | (5 | ) | | | 1 | | |
| | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | (544 | ) | | | | (1,033 | ) | | | 440 | | | | 49 | | |
Less: Preferred stock dividends | | | | 30 | | | | | — | | | | — | | | | 30 | | |
| | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | (574 | ) | | | $ | (1,033 | ) | | $ | 440 | | | $ | 19 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 7,865 | | | | $ | 6,663 | | | $ | 933 | | | $ | 269 | | |
| | | | | | | |
8
METLIFE, INC.
SUMMARY OF SEGMENT OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS (1)
| | | | | | | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
U.S. BUSINESS | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
INSURANCE PRODUCTS | | | $ | 155 | | | $ | 285 | | | $ | 302 | | | $ | 400 | | | | $ | 298 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
RETIREMENT PRODUCTS | | | | (118 | ) | | | 143 | | | | 105 | | | | 207 | | | | | 159 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
CORPORATE BENEFIT FUNDING | | | | 65 | | | | 155 | | | | 140 | | | | 191 | | | | | 228 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
AUTO & HOME | | | | 76 | | | | 76 | | | | 86 | | | | 84 | | | | | 72 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
U.S. BUSINESS TOTAL | | | $ | 178 | | | $ | 659 | | | $ | 633 | | | $ | 882 | | | | $ | 757 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
INTERNATIONAL | | | | 131 | | | | 158 | | | | 153 | | | | 21 | | | | | 151 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
BANKING, CORPORATE & OTHER | | | | (178 | ) | | | (94 | ) | | | (68 | ) | | | (110 | ) | | | | (74 | ) | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
METLIFE, INC. CONSOLIDATED | | | $ | 131 | | | $ | 723 | | | $ | 718 | | | $ | 793 | | | | $ | 834 | | |
| | | | | | | |
| | |
(1) | | A reconciliation of operating earnings available to common shareholders to net income (loss) for each segment appears in the QFS as follows: (i) Insurance Products, page 10, (ii) Retirement Products, page 17, (iii) Corporate Benefit Funding, page 21, (iv) Auto & Home, page 25, (v) International, page 29, and (vi) Banking, Corporate & Other, page 33. A consolidated reconciliation of operating earnings available to common shareholders to net income (loss) for MetLife, Inc. appears on page 4. |
9
U.S. BUSINESS
INSURANCE PRODUCTS
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended | | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 4,201 | | | $ | 4,235 | | | $ | 4,222 | | | $ | 4,510 | | | | $ | 4,323 | | | | | | | | | $ | 4,201 | | | | $ | 4,323 | | |
Universal life and investment-type product policy fees | | | | 583 | | | | 543 | | | | 533 | | | | 622 | | | | | 549 | | | | | | | | | | 583 | | | | | 549 | | |
Net investment income | | | | 1,281 | | | | 1,413 | | | | 1,437 | | | | 1,483 | | | | | 1,504 | | | | | | | | | | 1,281 | | | | | 1,504 | | |
Other revenues | | | | 177 | | | | 181 | | | | 221 | | | | 200 | | | | | 189 | | | | | | | | | | 177 | | | | | 189 | | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | 6,242 | | | | 6,372 | | | | 6,413 | | | | 6,815 | | | | | 6,565 | | | | | | | | | | 6,242 | | | | | 6,565 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | 4,748 | | | | 4,700 | | | | 4,745 | | | | 4,918 | | | | | 4,847 | | | | | | | | | | 4,748 | | | | | 4,847 | | |
Interest credited to policyholder account balances | | | | 231 | | | | 233 | | | | 240 | | | | 248 | | | | | 234 | | | | | | | | | | 231 | | | | | 234 | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | (206 | ) | | | (213 | ) | | | (218 | ) | | | (236 | ) | | | | (206 | ) | | | | | | | | | (206 | ) | | | | (206 | ) | |
Amortization of DAC and VOBA | | | | 210 | | | | 161 | | | | 145 | | | | 209 | | | | | 239 | | | | | | | | | | 210 | | | | | 239 | | |
Interest expense | | | | 1 | | | | 2 | | | | — | | | | 3 | | | | | — | | | | | | | | | | 1 | | | | | — | | |
Other expenses | | | | 1,023 | | | | 1,061 | | | | 1,048 | | | | 1,074 | | | | | 992 | | | | | | | | | | 1,023 | | | | | 992 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 6,007 | | | | 5,944 | | | | 5,960 | | | | 6,216 | | | | | 6,106 | | | | | | | | | | 6,007 | | | | | 6,106 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 235 | | | | 428 | | | | 453 | | | | 599 | | | | | 459 | | | | | | | | | | 235 | | | | | 459 | | |
Provision for income tax expense (benefit) | | | | 80 | | | | 143 | | | | 151 | | | | 199 | | | | | 161 | | | | | | | | | | 80 | | | | | 161 | | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | 155 | | | | 285 | | | | 302 | | | | 400 | | | | | 298 | | | | | | | | | | 155 | | | | | 298 | | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 155 | | | $ | 285 | | | $ | 302 | | | $ | 400 | | | | $ | 298 | | | | | | | | | $ | 155 | | | | $ | 298 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 155 | | | $ | 285 | | | $ | 302 | | | $ | 400 | | | | $ | 298 | | | | | | | | | $ | 155 | | | | $ | 298 | | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | (1,036 | ) | | | (878 | ) | | | (139 | ) | | | (205 | ) | | | | 33 | | | | | | | | | | (1,036 | ) | | | | 33 | | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | (6 | ) | | | (11 | ) | | | (4 | ) | | | (6 | ) | | | | (1 | ) | | | | | | | | | (6 | ) | | | | (1 | ) | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | (24 | ) | | | (19 | ) | | | (14 | ) | | | (17 | ) | | | | (35 | ) | | | | | | | | | (24 | ) | | | | (35 | ) | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | (11 | ) | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | (11 | ) | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | 7 | | | | (3 | ) | | | 1 | | | | (4 | ) | | | | (1 | ) | | | | | | | | | 7 | | | | | (1 | ) | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | (48 | ) | | | 81 | | | | (47 | ) | | | (14 | ) | | | | (10 | ) | | | | | | | | | (48 | ) | | | | (10 | ) | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | 390 | | | | 290 | | | | 72 | | | | 85 | | | | | 5 | | | | | | | | | | 390 | | | | | 5 | | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | (573 | ) | | | (255 | ) | | | 171 | | | | 239 | | | | | 289 | | | | | | | | | | (573 | ) | | | | 289 | | |
Income (loss) from discontinued operations, net of income tax | | | | 19 | | | | — | | | | — | | | | 3 | | | | | — | | | | | | | | | | 19 | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | (554 | ) | | | (255 | ) | | | 171 | | | | 242 | | | | | 289 | | | | | | | | | | (554 | ) | | | | 289 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | (554 | ) | | | (255 | ) | | | 171 | | | | 242 | | | | | 289 | | | | | | | | | | (554 | ) | | | | 289 | | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | (554 | ) | | $ | (255 | ) | | $ | 171 | | | $ | 242 | | | | $ | 289 | | | | | | | | | $ | (554 | ) | | | $ | 289 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 4,961 | | | $ | 4,959 | | | $ | 4,976 | | | $ | 5,332 | | | | $ | 5,061 | | | | | | | | | $ | 4,961 | | | | $ | 5,061 | | |
| | | | | | | | | | | | | | | | | | |
10
U.S. BUSINESS
INSURANCE PRODUCTS — GROUP LIFE
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS — PRODUCT LEVEL
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended | | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 1,745 | | | $ | 1,754 | | | $ | 1,739 | | | $ | 1,829 | | | | $ | 1,871 | | | | | | | | | $ | 1,745 | | | | $ | 1,871 | | |
Universal life and investment-type product policy fees | | | | 165 | | | | 163 | | | | 152 | | | | 145 | | | | | 152 | | | | | | | | | | 165 | | | | | 152 | | |
Net investment income | | | | 202 | | | | 199 | | | | 203 | | | | 200 | | | | | 207 | | | | | | | | | | 202 | | | | | 207 | | |
Other revenues | | | | 3 | | | | 2 | | | | 2 | | | | 2 | | | | | 3 | | | | | | | | | | 3 | | | | | 3 | | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | 2,115 | | | | 2,118 | | | | 2,096 | | | | 2,176 | | | | | 2,233 | | | | | | | | | | 2,115 | | | | | 2,233 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | 1,788 | | | | 1,776 | | | | 1,732 | | | | 1,821 | | | | | 1,865 | | | | | | | | | | 1,788 | | | | | 1,865 | | |
Interest credited to policyholder account balances | | | | 47 | | | | 46 | | | | 46 | | | | 47 | | | | | 44 | | | | | | | | | | 47 | | | | | 44 | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | (5 | ) | | | (4 | ) | | | (3 | ) | | | (4 | ) | | | | (4 | ) | | | | | | | | | (5 | ) | | | | (4 | ) | |
Amortization of DAC and VOBA | | | | 9 | | | | 6 | | | | 6 | | | | 4 | | | | | 5 | | | | | | | | | | 9 | | | | | 5 | | |
Interest expense | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses | | | | 147 | | | | 159 | | | | 151 | | | | 153 | | | | | 141 | | | | | | | | | | 147 | | | | | 141 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 1,986 | | | | 1,983 | | | | 1,932 | | | | 2,021 | | | | | 2,051 | | | | | | | | | | 1,986 | | | | | 2,051 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 129 | | | | 135 | | | | 164 | | | | 155 | | | | | 182 | | | | | | | | | | 129 | | | | | 182 | | |
Provision for income tax expense (benefit) | | | | 44 | | | | 46 | | | | 56 | | | | 52 | | | | | 64 | | | | | | | | | | 44 | | | | | 64 | | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | 85 | | | | 89 | | | | 108 | | | | 103 | | | | | 118 | | | | | | | | | | 85 | | | | | 118 | | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 85 | | | $ | 89 | | | $ | 108 | | | $ | 103 | | | | $ | 118 | | | | | | | | | $ | 85 | | | | $ | 118 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 85 | | | $ | 89 | | | $ | 108 | | | $ | 103 | | | | $ | 118 | | | | | | | | | $ | 85 | | | | $ | 118 | | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | (105 | ) | | | (116 | ) | | | (33 | ) | | | (4 | ) | | | | 25 | | | | | | | | | | (105 | ) | | | | 25 | | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | (16 | ) | | | (10 | ) | | | (6 | ) | | | (6 | ) | | | | (18 | ) | | | | | | | | | (16 | ) | | | | (18 | ) | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | 5 | | | | (2 | ) | | | 5 | | | | (4 | ) | | | | — | | | | | | | | | | 5 | | | | | — | | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | 40 | | | | 45 | | | | 12 | | | | 5 | | | | | (2 | ) | | | | | | | | | 40 | | | | | (2 | ) | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | 9 | | | | 6 | | | | 86 | | | | 94 | | | | | 123 | | | | | | | | | | 9 | | | | | 123 | | |
Income (loss) from discontinued operations, net of income tax | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | 9 | | | | 6 | | | | 86 | | | | 94 | | | | | 123 | | | | | | | | | | 9 | | | | | 123 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | 9 | | | | 6 | | | | 86 | | | | 94 | | | | | 123 | | | | | | | | | | 9 | | | | | 123 | | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | 9 | | | $ | 6 | | | $ | 86 | | | $ | 94 | | | | $ | 123 | | | | | | | | | $ | 9 | | | | $ | 123 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 1,913 | | | $ | 1,919 | | | $ | 1,893 | | | $ | 1,976 | | | | $ | 2,026 | | | | | | | | | $ | 1,913 | | | | $ | 2,026 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Group Life Mortality Ratio | | | | 91.8 | % | | | 90.4 | % | | | 89.2 | % | | | 89.7 | % | | | | 89.5 | % | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
11
U.S. BUSINESS
INSURANCE PRODUCTS — INDIVIDUAL LIFE
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS — PRODUCT LEVEL
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | For the Three Months Ended | | | | | | For the Year-to-Date Period Ended |
| | | March 31, | | June 30, | | September | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 30, 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 985 | | | $ | 1,026 | | | $ | 1,035 | | | $ | 1,154 | | | | $ | 967 | | | | | | | | | $ | 985 | | | | $ | 967 | | |
Universal life and investment-type product policy fees | | | | 415 | | | | 378 | | | | 378 | | | | 477 | | | | | 397 | | | | | | | | | | 415 | | | | | 397 | | |
Net investment income | | | | 943 | | | | 1,036 | | | | 1,036 | | | | 1,062 | | | | | 1,086 | | | | | | | | | | 943 | | | | | 1,086 | | |
Other revenues | | | | 76 | | | | 82 | | | | 114 | | | | 102 | | | | | 94 | | | | | | | | | | 76 | | | | | 94 | | |
| | | | | | | | | | | | |
Total operating revenues | | | | 2,419 | | | | 2,522 | | | | 2,563 | | | | 2,795 | | | | | 2,544 | | | | | | | | | | 2,419 | | | | | 2,544 | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | 1,674 | | | | 1,638 | | | | 1,700 | | | | 1,720 | | | | | 1,627 | | | | | | | | | | 1,674 | | | | | 1,627 | | |
Interest credited to policyholder account balances | | | | 178 | | | | 181 | | | | 188 | | | | 195 | | | | | 185 | | | | | | | | | | 178 | | | | | 185 | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | (151 | ) | | | (162 | ) | | | (169 | ) | | | (188 | ) | | | | (159 | ) | | | | | | | | | (151 | ) | | | | (159 | ) | |
Amortization of DAC and VOBA | | | | 164 | | | | 118 | | | | 102 | | | | 173 | | | | | 198 | | | | | | | | | | 164 | | | | | 198 | | |
Interest expense | | | | 1 | | | | 2 | | | | — | | | | 3 | | | | | — | | | | | | | | | | 1 | | | | | — | | |
Other expenses | | | | 522 | | | | 547 | | | | 546 | | | | 559 | | | | | 516 | | | | | | | | | | 522 | | | | | 516 | | |
| | | | | | | | | | | | | |
Total operating expenses | | | | 2,388 | | | | 2,324 | | | | 2,367 | | | | 2,462 | | | | | 2,367 | | | | | | | | | | 2,388 | | | | | 2,367 | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 31 | | | | 198 | | | | 196 | | | | 333 | | | | | 177 | | | | | | | | | | 31 | | | | | 177 | | |
Provision for income tax expense (benefit) | | | | 11 | | | | 65 | | | | 63 | | | | 110 | | | | | 62 | | | | | | | | | | 11 | | | | | 62 | | |
| | | | | | | | | | | | | |
Operating earnings | | | | 20 | | | | 133 | | | | 133 | | | | 223 | | | | | 115 | | | | | | | | | | 20 | | | | | 115 | | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 20 | | | $ | 133 | | | $ | 133 | | | $ | 223 | | | | $ | 115 | | | | | | | | | $ | 20 | | | | $ | 115 | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 20 | | | $ | 133 | | | $ | 133 | | | $ | 223 | | | | $ | 115 | | | | | | | | | $ | 20 | | | | $ | 115 | | |
| | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | (57 | ) | | | (373 | ) | | | (160 | ) | | | (16 | ) | | | | 6 | | | | | | | | | | (57 | ) | | | | 6 | | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | (6 | ) | | | (11 | ) | | | (4 | ) | | | (6 | ) | | | | (1 | ) | | | | | | | | | (6 | ) | | | | (1 | ) | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | (2 | ) | | | (2 | ) | | | — | | | | (2 | ) | | | | (10 | ) | | | | | | | | | (2 | ) | | | | (10 | ) | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | (11 | ) | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | (11 | ) | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | (48 | ) | | | 81 | | | | (47 | ) | | | (14 | ) | | | | (10 | ) | | | | | | | | | (48 | ) | | | | (10 | ) | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | 44 | | | | 105 | | | | 75 | | | | 13 | | | | | 5 | | | | | | | | | | 44 | | | | | 5 | | |
| | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | (60 | ) | | | (67 | ) | | | (3 | ) | | | 198 | | | | | 105 | | | | | | | | | | (60 | ) | | | | 105 | | |
Income (loss) from discontinued operations, net of income tax | | | | 19 | | | | — | | | | — | | | | 3 | | | | | — | | | | | | | | | | 19 | | | | | — | | |
| | | | | | | | | | | | | |
Net income (loss) | | | | (41 | ) | | | (67 | ) | | | (3 | ) | | | 201 | | | | | 105 | | | | | | | | | | (41 | ) | | | | 105 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | (41 | ) | | | (67 | ) | | | (3 | ) | | | 201 | | | | | 105 | | | | | | | | | | (41 | ) | | | | 105 | | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | (41 | ) | | $ | (67 | ) | | $ | (3 | ) | | $ | 201 | | | | $ | 105 | | | | | | | | | $ | (41 | ) | | | $ | 105 | | |
| | | | | | | | | | | | |
| | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 1,476 | | | $ | 1,486 | | | $ | 1,527 | | | $ | 1,733 | | | | $ | 1,458 | | | | | | | | | $ | 1,476 | | | | $ | 1,458 | | |
| | | | | | | | | | | |
| | | | | | |
| | | | | | | | | | | | | | | | | | | |
Mortality as a Percentage of Expected | | | | 82.6 | % | | | 74.9 | % | | | 91.2 | % | | | 81.1 | % | | | | 87.6 | % | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | |
Lapse Ratio | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Traditional Life | | | | 6.4 | % | | | 6.7 | % | | | 6.9 | % | | | 6.8 | % | | | | 6.7 | % | | | | | | | | | | | | | | | | |
Variable & Universal Life | | | | 6.2 | % | | | 6.6 | % | | | 6.8 | % | | | 6.5 | % | | | | 6.1 | % | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
12
U.S. BUSINESS
INSURANCE PRODUCTS — NON-MEDICAL HEALTH
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS — PRODUCT LEVEL
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | | For the Three Months Ended | | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 1,471 | | | $ | 1,455 | | | $ | 1,448 | | | $ | 1,527 | | | | $ | 1,485 | | | | | | | | | $ | 1,471 | | | | $ | 1,485 | | |
Universal life and investment-type product policy fees | | | | 3 | | | | 2 | | | | 3 | | | | — | | | | | — | | | | | | | | | | 3 | | | | | — | | |
Net investment income | | | | 136 | | | | 178 | | | | 198 | | | | 221 | | | | | 211 | | | | | | | | | | 136 | | | | | 211 | | |
Other revenues | | | | 98 | | | | 97 | | | | 105 | | | | 96 | | | | | 92 | | | | | | | | | | 98 | | | | | 92 | | |
| | | | | | | | | | | | |
Total operating revenues | | | | 1,708 | | | | 1,732 | | | | 1,754 | | | | 1,844 | | | | | 1,788 | | | | | | | | | | 1,708 | | | | | 1,788 | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | 1,286 | | | | 1,286 | | | | 1,313 | | | | 1,377 | | | | | 1,355 | | | | | | | | | | 1,286 | | | | | 1,355 | | |
Interest credited to policyholder account balances | | | | 6 | | | | 6 | | | | 6 | | | | 6 | | | | | 5 | | | | | | | | | | 6 | | | | | 5 | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | (50 | ) | | | (47 | ) | | | (46 | ) | | | (44 | ) | | | | (43 | ) | | | | | | | | | (50 | ) | | | | (43 | ) | |
Amortization of DAC and VOBA | | | | 37 | | | | 37 | | | | 37 | | | | 32 | | | | | 36 | | | | | | | | | | 37 | | | | | 36 | | |
Interest expense | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses | | | | 354 | | | | 355 | | | | 351 | | | | 362 | | | | | 335 | | | | | | | | | | 354 | | | | | 335 | | |
| | | | | | | | | | | | |
Total operating expenses | | | | 1,633 | | | | 1,637 | | | | 1,661 | | | | 1,733 | | | | | 1,688 | | | | | | | | | | 1,633 | | | | | 1,688 | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 75 | | | | 95 | | | | 93 | | | | 111 | | | | | 100 | | | | | | | | | | 75 | | | | | 100 | | |
Provision for income tax expense (benefit) | | | | 25 | | | | 32 | | | | 32 | | | | 37 | | | | | 35 | | | | | | | | | | 25 | | | | | 35 | | |
| | | | | | | | | | | | |
Operating earnings | | | | 50 | | | | 63 | | | | 61 | | | | 74 | | | | | 65 | | | | | | | | | | 50 | | | | | 65 | | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 50 | | | $ | 63 | | | $ | 61 | | | $ | 74 | | | | $ | 65 | | | | | | | | | $ | 50 | | | | $ | 65 | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 50 | | | $ | 63 | | | $ | 61 | | | $ | 74 | | | | $ | 65 | | | | | | | | | $ | 50 | | | | $ | 65 | | |
| | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | (874 | ) | | | (389 | ) | | | 54 | | | | (185 | ) | | | | 2 | | | | | | | | | | (874 | ) | | | | 2 | | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | (6 | ) | | | (7 | ) | | | (8 | ) | | | (9 | ) | | | | (7 | ) | | | | | | | | | (6 | ) | | | | (7 | ) | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | 2 | | | | (1 | ) | | | (4 | ) | | | — | | | | | (1 | ) | | | | | | | | | 2 | | | | | (1 | ) | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | 306 | | | | 140 | | | | (15 | ) | | | 67 | | | | | 2 | | | | | | | | | | 306 | | | | | 2 | | |
| | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | (522 | ) | | | (194 | ) | | | 88 | | | | (53 | ) | | | | 61 | | | | | | | | | | (522 | ) | | | | 61 | | |
Income (loss) from discontinued operations, net of income tax | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | |
Net income (loss) | | | | (522 | ) | | | (194 | ) | | | 88 | | | | (53 | ) | | | | 61 | | | | | | | | | | (522 | ) | | | | 61 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | (522 | ) | | | (194 | ) | | | 88 | | | | (53 | ) | | | | 61 | | | | | | | | | | (522 | ) | | | | 61 | | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | (522 | ) | | $ | (194 | ) | | $ | 88 | | | $ | (53 | ) | | | $ | 61 | | | | | | | | | $ | (522 | ) | | | $ | 61 | | |
| | | | | | | | | | | | |
| |
| | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 1,572 | | | $ | 1,554 | | | $ | 1,556 | | | $ | 1,623 | | | | $ | 1,577 | | | | | | | | | $ | 1,572 | | | | $ | 1,577 | | |
| | | | | | | | | | | |
| |
| | | | | | | | | | | | | | | | | | | |
Non-Medical Health Benefit Ratio | | | | 87.4 | % | | | 88.4 | % | | | 90.7 | % | | | 90.2 | % | | | | 91.2 | % | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
13
U.S. BUSINESS
INSURANCE PRODUCTS
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES; AND SEPARATE ACCOUNT LIABILITIES
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES
| | | | | | | | | | | | | | | | | | | | | | | |
GROUP LIFE | | |
| | |
| | For the Three Months Ended |
| | | March 31, | | | June 30, | | | September 30, | | | December 31, | | | | March 31, | | |
Unaudited (In millions) | | | 2009 | | | 2009 | | | 2009 | | | 2009 | | | | 2010 | | |
| | |
Balance, beginning of period | | | $ | 11,406 | | | $ | 11,654 | | | $ | 11,842 | | | $ | 11,911 | | | | $ | 11,966 | | |
Premiums and deposits | | | | 3,633 | | | | 3,670 | | | | 3,600 | | | | 3,486 | | | | | 3,598 | | |
Surrenders and withdrawals | | | | (1,314 | ) | | | (1,404 | ) | | | (1,467 | ) | | | (1,363 | ) | | | | (1,361 | ) | |
Benefit payments | | | | (2,002 | ) | | | (1,985 | ) | | | (1,969 | ) | | | (1,914 | ) | | | | (1,970 | ) | |
| | | |
Net Flows | | | | 317 | | | | 281 | | | | 164 | | | | 209 | | | | | 267 | | |
Net transfers from (to) separate account | | | | 1 | | | | 1 | | | | 2 | | | | 1 | | | | | 1 | | |
Interest | | | | 80 | | | | 78 | | | | 76 | | | | 76 | | | | | 72 | | |
Policy charges | | | | (135 | ) | | | (136 | ) | | | (132 | ) | | | (135 | ) | | | | (128 | ) | |
Other | | | | (15 | ) | | | (36 | ) | | | (41 | ) | | | (96 | ) | | | | (118 | ) | |
| | | |
Balance, end of period | | | $ | 11,654 | | | $ | 11,842 | | | $ | 11,911 | | | $ | 11,966 | | | | $ | 12,060 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
INDIVIDUAL LIFE | | | | | |
| | |
| | For the Three Months Ended |
| | | March 31, | | | June 30, | | | September 30, | | | December 31, | | | | March 31, | | |
Unaudited (In millions) | | | 2009 | | | 2009 | | | 2009 | | | 2009 | | | | 2010 | | |
| | |
Balance, beginning of period | | | $ | 71,686 | | | $ | 72,457 | | | $ | 72,920 | | | $ | 73,307 | | | | $ | 73,934 | | |
Premiums and deposits | | | | 2,031 | | | | 2,034 | | | | 2,049 | | | | 2,167 | | | | | 2,070 | | |
Surrenders and withdrawals | | | | (978 | ) | | | (1,026 | ) | | | (978 | ) | | | (936 | ) | | | | (908 | ) | |
Benefit payments | | | | (612 | ) | | | (569 | ) | | | (576 | ) | | | (577 | ) | | | | (670 | ) | |
| | | |
Net Flows | | | | 441 | | | | 439 | | | | 495 | | | | 654 | | | | | 492 | | |
Net transfers from (to) separate account | | | | 31 | | | | 127 | | | | (14 | ) | | | 39 | | | | | 29 | | |
Interest | | | | 733 | | | | 736 | | | | 755 | | | | 763 | | | | | 749 | | |
Policy charges | | | | (391 | ) | | | (394 | ) | | | (389 | ) | | | (397 | ) | | | | (401 | ) | |
Other | | | | (43 | ) | | | (445 | ) | | | (460 | ) | | | (432 | ) | | | | (405 | ) | |
| | | |
Balance, end of period | | | $ | 72,457 | | | $ | 72,920 | | | $ | 73,307 | | | $ | 73,934 | | | | $ | 74,398 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
NON-MEDICAL HEALTH | | | | | |
| | |
| | For the Three Months Ended |
| | | March 31, | | | June 30, | | | September 30, | | | December 31, | | | | March 31, | | |
Unaudited (In millions) | | | 2009 | | | 2009 | | | 2009 | | | 2009 | | | | 2010 | | |
| | |
Balance, beginning of period | | | $ | 12,120 | | | $ | 12,367 | | | $ | 12,579 | | | $ | 12,868 | | | | $ | 13,239 | | |
Premiums and deposits | | | | 1,527 | | | | 1,500 | | | | 1,585 | | | | 1,567 | | | | | 1,518 | | |
Surrenders and withdrawals | | | | (6 | ) | | | (6 | ) | | | (106 | ) | | | (5 | ) | | | | (5 | ) | |
Benefit payments | | | | (1,055 | ) | | | (1,104 | ) | | | (1,074 | ) | | | (1,084 | ) | | | | (1,137 | ) | |
| | | | | | |
Net Flows | | | | 466 | | | | 390 | | | | 405 | | | | 478 | | | | | 376 | | |
Net transfers from (to) separate account | | | | — | | | | — | | | | — | | | | — | | | | | — | | |
Interest | | | | 131 | | | | 135 | | | | 140 | | | | 147 | | | | | 148 | | |
Policy charges | | | | — | | | | — | | | | — | | | | — | | | | | — | | |
Other | | | | (350 | ) | | | (313 | ) | | | (256 | ) | | | (254 | ) | | | | (279 | ) | |
| | | | | | |
Balance, end of period | | | $ | 12,367 | | | $ | 12,579 | | | $ | 12,868 | | | $ | 13,239 | | | | $ | 13,484 | | |
| | | | | | | |
SEPARATE ACCOUNT LIABILITIES
| | | | | | | | | | | | | | | | | | | | | | | |
GROUP LIFE | | | | | |
| | |
| | For the Three Months Ended |
| | | March 31, | | | June 30, | | | September 30, | | | December 31, | | | | March 31, | | |
Unaudited (In millions) | | | 2009 | | | 2009 | | | 2009 | | | 2009 | | | | 2010 | | |
| | |
Balance, beginning of period | | | $ | 334 | | | $ | 316 | | | $ | 366 | | | $ | 416 | | | | $ | 433 | | |
Premiums and deposits | | | | 39 | | | | 39 | | | | 38 | | | | 39 | | | | | 40 | | |
Surrenders and withdrawals | | | | (6 | ) | | | (6 | ) | | | (10 | ) | | | (9 | ) | | | | (9 | ) | |
Benefit payments | | | | (2 | ) | | | 1 | | | | — | | | | — | | | | | (1 | ) | |
| | | | | | |
Net Flows | | | | 31 | | | | 34 | | | | 28 | | | | 30 | | | | | 30 | | |
Investment Performance | | | | (20 | ) | | | 47 | | | | 53 | | | | 18 | | | | | 19 | | |
Net transfers from (to) general account | | | | (1 | ) | | | (1 | ) | | | (2 | ) | | | (1 | ) | | | | (1 | ) | |
Policy charges | | | | (29 | ) | | | (29 | ) | | | (29 | ) | | | (30 | ) | | | | (31 | ) | |
Other | | | | 1 | | | | (1 | ) | | | — | | | | — | | | | | — | | |
| | | | | | | |
Balance, end of period | | | $ | 316 | | | $ | 366 | | | $ | 416 | | | $ | 433 | | | | $ | 450 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
INDIVIDUAL LIFE | | | | | |
| | |
| | For the Three Months Ended |
| | | March 31, | | | June 30, | | | September 30, | | | December 31, | | | | March 31, | | |
Unaudited (In millions) | | | 2009 | | | 2009 | | | 2009 | | | 2009 | | | | 2010 | | |
| | |
Balance, beginning of period | | | $ | 7,193 | | | $ | 6,744 | | | $ | 7,313 | | | $ | 8,232 | | | | $ | 8,405 | | |
Premiums and deposits | | | | 228 | | | | 216 | | | | 210 | | | | 215 | | | | | 208 | | |
Surrenders and withdrawals | | | | (136 | ) | | | (119 | ) | | | (103 | ) | | | (140 | ) | | | | (124 | ) | |
Benefit payments | | | | (8 | ) | | | (7 | ) | | | (10 | ) | | | (7 | ) | | | | (8 | ) | |
| | | |
Net Flows | | | | 84 | | | | 90 | | | | 97 | | | | 68 | | | | | 76 | | |
Investment Performance | | | | (351 | ) | | | 755 | | | | 953 | | | | 297 | | | | | 374 | | |
Net transfers from (to) general account | | | | (31 | ) | | | (127 | ) | | | 14 | | | | (39 | ) | | | | (29 | ) | |
Policy charges | | | | (150 | ) | | | (147 | ) | | | (147 | ) | | | (147 | ) | | | | (143 | ) | |
Other | | | | (1 | ) | | | (2 | ) | | | 2 | | | | (6 | ) | | | | (1 | ) | |
| | | |
Balance, end of period | | | $ | 6,744 | | | $ | 7,313 | | | $ | 8,232 | | | $ | 8,405 | | | | $ | 8,682 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
NON-MEDICAL HEALTH | | | | | |
| | |
| | For the Three Months Ended |
| | | March 31, | | | June 30, | | | September 30, | | | December 31, | | | | March 31, | | |
Unaudited (In millions) | | | 2009 | | | 2009 | | | 2009 | | | 2009 | | | | 2010 | | |
| | |
Balance, beginning of period | | | $ | 763 | | | $ | 793 | | | $ | 832 | | | $ | 911 | | | | $ | — | | |
Premiums and deposits | | | | 40 | | | | 38 | | | | 38 | | | | — | | | | | — | | |
Surrenders and withdrawals | | | | (3 | ) | | | (4 | ) | | | (4 | ) | | | (910 | ) | | | | — | | |
Benefit payments | | | | — | | | | — | | | | — | | | | — | | | | | — | | |
| | | | | | | |
Net Flows | | | | 37 | | | | 34 | | | | 34 | | | | (910 | ) | | | | — | | |
Investment Performance | | | | — | | | | 11 | | | | 30 | | | | (1 | ) | | | | — | | |
Net transfers from (to) general account | | | | — | | | | — | | | | — | | | | — | | | | | — | | |
Policy charges | | | | (6 | ) | | | (6 | ) | | | (8 | ) | | | — | | | | | — | | |
Other | | | | (1 | ) | | | — | | | | 23 | | | | — | | | | | — | | |
| | | | | | | |
Balance, end of period | | | $ | 793 | | | $ | 832 | | | $ | 911 | | | $ | — | | | | $ | — | | |
| | | | | | | |
14
U.S. BUSINESS
INSURANCE PRODUCTS
OTHER EXPENSES BY MAJOR CATEGORY AND INDIVIDUAL LIFE SALES BY PRODUCT
| | | | | | | | | | | | | | | | | | | | | | | |
OTHER EXPENSES | | | | |
| | |
| | For the Three Months Ended |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | |
Direct and allocated expenses (1) | | | $ | 582 | | | $ | 577 | | | $ | 568 | | | $ | 579 | | | | $ | 554 | | |
Pension and post-retirement benefit costs | | | | 55 | | | | 73 | | | | 70 | | | | 69 | | | | | 51 | | |
Premium taxes, other taxes, and licenses & fees | | | | 82 | | | | 83 | | | | 82 | | | | 75 | | | | | 69 | | |
| | | |
Total fixed operating expenses | | | $ | 719 | | | $ | 733 | | | $ | 720 | | | $ | 723 | | | | $ | 674 | | |
| | | |
Commissions and other variable expenses (1) | | | | 304 | | | | 328 | | | | 328 | | | | 351 | | | | | 318 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Total other expenses | | | $ | 1,023 | | | $ | 1,061 | | | $ | 1,048 | | | $ | 1,074 | | | | $ | 992 | | |
| | | |
| | | | | | | | | | | | | | | | | | | | | | | |
INDIVIDUAL LIFE SALES BY PRODUCT (2) | | | | |
| | |
| | For the Three Months Ended |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | |
Individual Life Sales | | | | | | | | | | | | | | | | | | | | | | | |
Term Life | | | $ | 28 | | | $ | 34 | | | $ | 37 | | | $ | 37 | | | | $ | 33 | | |
Whole Life | | | | 21 | | | | 32 | | | | 30 | | | | 34 | | | | | 29 | | |
Variable Life | | | | 10 | | | | 13 | | | | 10 | | | | 10 | | | | | 9 | | |
Universal Life | | | | 38 | | | | 44 | | | | 50 | | | | 63 | | | | | 41 | | |
| | | |
Total Individual Life sales (3) | | | $ | 97 | | | $ | 123 | | | $ | 127 | | | $ | 144 | | | | $ | 112 | | |
| | | |
| | |
(1) | | Certain reclassifications were made between direct and allocated expenses and commissions and other variable expenses for the March 31, 2009 and June 30, 2009 periods to conform to current period presentation. There is no impact to total other expenses for the periods modified. |
|
(2) | | Statistical sales information is calculated by MetLife using the LIMRA International, Inc. definition of sales for core direct sales, excluding company sponsored internal exchanges, corporate-owned life insurance, bank-owned life insurance, and private placement variable universal life insurance. |
|
(3) | | Of the $112 million of First Year Individual Life sales during the three months ended March 31, 2010, approximately 44% were distributed through MetLife agents, 14% through New England Financial agents, 40% through MetLife’s third party channels and 2% through other channels. |
15
U.S. BUSINESS
INSURANCE PRODUCTS
SPREAD BY PRODUCT
GROUP LIFE
| | | | | | | | | | | | | | | | | | | | | | | |
| | |
| | For the Three Months Ended |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | |
Investment income yield | | | | 5.17 | % | | | 5.08 | % | | | 5.20 | % | | | 5.02 | % | | | | 5.42 | % | |
Average crediting rate | | | | 2.45 | % | | | 2.33 | % | | | 2.20 | % | | | 2.18 | % | | | | 2.15 | % | |
| | | |
Annualized general account spread | | | | 2.72 | % | | | 2.75 | % | | | 3.00 | % | | | 2.84 | % | | | | 3.27 | % | |
| | | |
VARIABLE & UNIVERSAL LIFE
| | | | | | | | | | | | | | | | | | | | | | | |
| | |
| | For the Three Months Ended |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | |
Investment income yield | | | | 4.97 | % | | | 6.24 | % | | | 6.07 | % | | | 6.27 | % | | | | 6.28 | % | |
Average crediting rate | | | | 4.59 | % | | | 4.56 | % | | | 4.58 | % | | | 4.69 | % | | | | 4.47 | % | |
| | | |
Annualized general account spread (1) | | | | 0.38 | % | | | 1.68 | % | | | 1.49 | % | | | 1.58 | % | | | | 1.81 | % | |
| | | |
NON-MEDICAL HEALTH
| | | | | | | | | | | | | | | | | | | | | | | |
| | |
| | For the Three Months Ended |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | |
Investment income yield | | | | 3.60 | % | | | 5.01 | % | | | 5.57 | % | | | 6.14 | % | | | | 5.95 | % | |
Average crediting rate | | | | 4.68 | % | | | 4.76 | % | | | 4.69 | % | | | 4.81 | % | | | | 4.80 | % | |
| | | |
Annualized general account spread | | | | (1.08 | %) | | | 0.25 | % | | | 0.88 | % | | | 1.33 | % | | | | 1.15 | % | |
| | | |
| | |
(1) | | This represents the general account spread for Variable and Universal Life, a component of Individual Life. |
16
U.S. BUSINESS
RETIREMENT PRODUCTS
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended | | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 152 | | | $ | 139 | | | $ | 140 | | | $ | 192 | | | | $ | 123 | | | | | | | | | $ | 152 | | | | $ | 123 | | |
Universal life and investment-type product policy fees | | | | 356 | | | | 397 | | | | 466 | | | | 493 | | | | | 513 | | | | | | | | | | 356 | | | | | 513 | | |
Net investment income | | | | 623 | | | | 724 | | | | 749 | | | | 763 | | | | | 773 | | | | | | | | | | 623 | | | | | 773 | | |
Other revenues | | | | 30 | | | | 34 | | | | 61 | | | | 47 | | | | | 48 | | | | | | | | | | 30 | | | | | 48 | | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | 1,161 | | | | 1,294 | | | | 1,416 | | | | 1,495 | | | | | 1,457 | | | | | | | | | | 1,161 | | | | | 1,457 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | 325 | | | | 353 | | | | 424 | | | | 296 | | | | | 354 | | | | | | | | | | 325 | | | | | 354 | | |
Interest credited to policyholder account balances | | | | 402 | | | | 428 | | | | 431 | | | | 426 | | | | | 406 | | | | | | | | | | 402 | | | | | 406 | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | (329 | ) | | | (285 | ) | | | (223 | ) | | | (230 | ) | | | | (234 | ) | | | | | | | | | (329 | ) | | | | (234 | ) | |
Amortization of DAC and VOBA | | | | 326 | | | | (44 | ) | | | 42 | | | | 100 | | | | | 133 | | | | | | | | | | 326 | | | | | 133 | | |
Interest expense | | | | — | | | | 1 | | | | — | | | | (1 | ) | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses | | | | 619 | | | | 621 | | | | 580 | | | | 585 | | | | | 554 | | | | | | | | | | 619 | | | | | 554 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 1,343 | | | | 1,074 | | | | 1,254 | | | | 1,176 | | | | | 1,213 | | | | | | | | | | 1,343 | | | | | 1,213 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | (182 | ) | | | 220 | | | | 162 | | | | 319 | | | | | 244 | | | | | | | | | | (182 | ) | | | | 244 | | |
Provision for income tax expense (benefit) | | | | (64 | ) | | | 77 | | | | 57 | | | | 112 | | | | | 85 | | | | | | | | | | (64 | ) | | | | 85 | | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | (118 | ) | | | 143 | | | | 105 | | | | 207 | | | | | 159 | | | | | | | | | | (118 | ) | | | | 159 | | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | (118 | ) | | $ | 143 | | | $ | 105 | | | $ | 207 | | | | $ | 159 | | | | | | | | | $ | (118 | ) | | | $ | 159 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | (118 | ) | | $ | 143 | | | $ | 105 | | | $ | 207 | | | | $ | 159 | | | | | | | | | $ | (118 | ) | | | $ | 159 | | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | 150 | | | | (1,120 | ) | | | (462 | ) | | | (174 | ) | | | | 101 | | | | | | | | | | 150 | | | | | 101 | | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | (50 | ) | | | (55 | ) | | | (49 | ) | | | (63 | ) | | | | (65 | ) | | | | | | | | | (50 | ) | | | | (65 | ) | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | (135 | ) | | | 544 | | | | 221 | | | | 109 | | | | | (4 | ) | | | | | | | | | (135 | ) | | | | (4 | ) | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | 11 | | | | 221 | | | | 103 | | | | 45 | | | | | (11 | ) | | | | | | | | | 11 | | | | | (11 | ) | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | (142 | ) | | | (267 | ) | | | (82 | ) | | | 124 | | | | | 180 | | | | | | | | | | (142 | ) | | | | 180 | | |
Income (loss) from discontinued operations, net of income tax | | | | 5 | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | 5 | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | (137 | ) | | | (267 | ) | | | (82 | ) | | | 124 | | | | | 180 | | | | | | | | | | (137 | ) | | | | 180 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | (137 | ) | | | (267 | ) | | | (82 | ) | | | 124 | | | | | 180 | | | | | | | | | | (137 | ) | | | | 180 | | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | (137 | ) | | $ | (267 | ) | | $ | (82 | ) | | $ | 124 | | | | $ | 180 | | | | | | | | | $ | (137 | ) | | | $ | 180 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 538 | | | $ | 570 | | | $ | 667 | | | $ | 732 | | | | $ | 684 | | | | | | | | | $ | 538 | | | | $ | 684 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Lapse Ratio | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Fixed Annuities | | | | 10.4 | % | | | 9.4 | % | | | 8.6 | % | | | 7.5 | % | | | | 6.8 | % | | | | | | | | | | | | | | | | |
Variable Annuities | | | | 9.3 | % | | | 8.6 | % | | | 7.9 | % | | | 7.1 | % | | | | 6.8 | % | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
17
U.S. BUSINESS
RETIREMENT PRODUCTS
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES; AND SEPARATE ACCOUNT LIABILITIES
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES
| | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended |
| | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
Balance, beginning of period | | | $ | 47,937 | | | $ | 51,415 | | | $ | 51,228 | | | $ | 51,388 | | | | $ | 50,799 | | |
Premiums and deposits (1), (2) | | | | 5,335 | | | | 2,768 | | | | 1,944 | | | | 1,766 | | | | | 1,606 | | |
Surrenders and withdrawals | | | | (1,413 | ) | | | (923 | ) | | | (890 | ) | | | (1,044 | ) | | | | (847 | ) | |
Benefit payments | | | | (315 | ) | | | (374 | ) | | | (363 | ) | | | (336 | ) | | | | (374 | ) | |
| | | | | | | |
Net Flows | | | | 3,607 | | | | 1,471 | | | | 691 | | | | 386 | | | | | 385 | | |
Net transfers from (to) separate account | | | | (231 | ) | | | (1,217 | ) | | | (1,107 | ) | | | (946 | ) | | | | (892 | ) | |
Interest | | | | 495 | | | | 529 | | | | 522 | | | | 518 | | | | | 494 | | |
Policy charges | | | | (11 | ) | | | (12 | ) | | | (10 | ) | | | (10 | ) | | | | (12 | ) | |
Other | | | | (382 | ) | | | (958 | ) | | | 64 | | | | (537 | ) | | | | (211 | ) | |
| | | | | | | |
Balance, end of period | | | $ | 51,415 | | | $ | 51,228 | | | $ | 51,388 | | | $ | 50,799 | | | | $ | 50,563 | | |
| | | | | | | |
SEPARATE ACCOUNT LIABILITIES
| | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended |
| | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
Balance, beginning of period | | | $ | 62,264 | | | $ | 59,194 | | | $ | 70,538 | | | $ | 82,100 | | | | $ | 87,113 | | |
Premiums and deposits (1) | | | | 2,260 | | | | 2,894 | | | | 2,279 | | | | 2,633 | | | | | 3,004 | | |
Surrenders and withdrawals | | | | (1,230 | ) | | | (1,176 | ) | | | (1,283 | ) | | | (1,456 | ) | | | | (1,625 | ) | |
Benefit payments | | | | (120 | ) | | | (141 | ) | | | (140 | ) | | | (150 | ) | | | | (178 | ) | |
| | | | | | | |
Net Flows | | | | 910 | | | | 1,577 | | | | 856 | | | | 1,027 | | | | | 1,201 | | |
Investment Performance | | | | (3,945 | ) | | | 8,872 | | | | 9,964 | | | | 3,430 | | | | | 3,755 | | |
Net transfers from (to) general account | | | | 231 | | | | 1,217 | | | | 1,107 | | | | 946 | | | | | 892 | | |
Policy charges | | | | (271 | ) | | | (322 | ) | | | (366 | ) | | | (392 | ) | | | | (406 | ) | |
Other | | | | 5 | | | | — | | | | 1 | | | | 2 | | | | | (1 | ) | |
| | | | | | | |
Balance, end of period | | | $ | 59,194 | | | $ | 70,538 | | | $ | 82,100 | | | $ | 87,113 | | | | $ | 92,554 | | |
| | | | | | | |
| | |
(1) | | Includes company sponsored internal exchanges. |
|
(2) | | Includes premiums and deposits directed to the General Account investment option of a variable annuity product. |
18
U.S. BUSINESS
RETIREMENT PRODUCTS
OTHER EXPENSES BY MAJOR CATEGORY AND INDIVIDUAL ANNUITY SALES BY PRODUCT
OTHER EXPENSES
| | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Direct and allocated expenses (1) | | | $ | 185 | | | $ | 192 | | | $ | 183 | | | $ | 178 | | | | $ | 173 | | |
Pension and post-retirement benefit costs | | | | 18 | | | | 25 | | | | 22 | | | | 22 | | | | | 20 | | |
Premium taxes, other taxes, and licenses & fees | | | | 2 | | | | 2 | | | | 7 | | | | 10 | | | | | 7 | | |
| | | | | | | |
Total fixed operating expenses | | | $ | 205 | | | $ | 219 | | | $ | 212 | | | $ | 210 | | | | $ | 200 | | |
| | | | | | | |
Commissions and other variable expenses (1) | | | | 414 | | | | 402 | | | | 368 | | | | 375 | | | | | 354 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Total other expenses | | | $ | 619 | | | $ | 621 | | | $ | 580 | | | $ | 585 | | | | $ | 554 | | |
| | | | | | | |
INDIVIDUAL ANNUITY SALES BY PRODUCT (2)
| | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (in millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Individual Annuity Sales | | | | | | | | | | | | | | | | | | | | | | | |
Annuities Sales (2) | | | | | | | | | | | | | | | | | | | | | | | |
Fixed annuity sales | | | $ | 3,645 | | | $ | 949 | | | $ | 596 | | | $ | 499 | | | | $ | 359 | | |
Variable annuity sales | | | | 3,737 | | | | 4,507 | | | | 3,441 | | | | 3,711 | | | | | 4,034 | | |
| | | | | | | |
Total annuity sales (3) | | | $ | 7,382 | | | $ | 5,456 | | | $ | 4,037 | | | $ | 4,210 | | | | $ | 4,393 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Separate Account and General Account | | | | | | | | | | | | | | | | | | | | | | | |
Separate Accounts | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
Total variable annuities separate accounts | | | $ | 2,147 | | | $ | 2,775 | | | $ | 2,171 | | | $ | 2,518 | | | | $ | 2,875 | | |
| | | | | | | |
General Accounts | | | | | | | | | | | | | | | | | | | | | | | |
Fixed annuity | | | | 3,645 | | | | 949 | | | | 596 | | | | 499 | | | | | 359 | | |
Variable annuity | | | | 1,590 | | | | 1,732 | | | | 1,270 | | | | 1,193 | | | | | 1,159 | | |
| | | | | | | |
Total general accounts | | | | 5,235 | | | | 2,681 | | | | 1,866 | | | | 1,692 | | | | | 1,518 | | |
| | | | | | | |
Total premiums and deposits | | | $ | 7,382 | | | $ | 5,456 | | | $ | 4,037 | | | $ | 4,210 | | | | $ | 4,393 | | |
| | | | | | | |
| | |
(1) | | Certain reclassifications were made between direct and allocated expenses and commissions and other variable expenses for the March 31, 2009 and June 30, 2009 periods to conform to current period presentation. There is no impact to total other expenses for the periods modified. |
|
(2) | | Statutory premiums direct and assumed, excluding company sponsored internal exchanges. |
|
(3) | | Of the $4,393 million of Annuity Sales during the three months ended March 31, 2010, approximately 21% were distributed through MetLife agents, 6% through New England Financial agents, 63% through MetLife’s third party channels, 9% through MetLife Resources representatives and 1% through other distribution channels. |
19
U.S. BUSINESS
RETIREMENT PRODUCTS
SPREAD
DEFERRED ANNUITIES
| | | | | | | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Investment income yield | | | | 5.20 | % | | | 5.84 | % | | | 5.86 | % | | | 5.92 | % | | | | 6.19 | % | |
Average crediting rate | | | | 3.86 | % | | | 3.96 | % | | | 3.88 | % | | | 3.85 | % | | | | 3.75 | % | |
| | | | | | | |
Annualized general account spread | | | | 1.34 | % | | | 1.88 | % | | | 1.98 | % | | | 2.07 | % | | | | 2.44 | % | |
| | | | | | | |
20
U.S. BUSINESS
CORPORATE BENEFIT FUNDING
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | For the Three Months Ended | | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 324 | | | $ | 695 | | | $ | 639 | | | $ | 903 | | | | $ | 801 | | | | | | | | | $ | 324 | | | | $ | 801 | | |
Universal life and investment-type product policy fees | | | | 40 | | | | 61 | | | | 34 | | | | 41 | | | | | 55 | | | | | | | | | | 40 | | | | | 55 | | |
Net investment income | | | | 1,111 | | | | 1,179 | | | | 1,210 | | | | 1,266 | | | | | 1,270 | | | | | | | | | | 1,111 | | | | | 1,270 | | |
Other revenues | | | | 69 | | | | 69 | | | | 34 | | | | 67 | | | | | 64 | | | | | | | | | | 69 | | | | | 64 | | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | 1,544 | | | | 2,004 | | | | 1,917 | | | | 2,277 | | | | | 2,190 | | | | | | | | | | 1,544 | | | | | 2,190 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | 879 | | | | 1,240 | | | | 1,192 | | | | 1,486 | | | | | 1,362 | | | | | | | | | | 879 | | | | | 1,362 | | |
Interest credited to policyholder account balances | | | | 459 | | | | 409 | | | | 390 | | | | 375 | | | | | 355 | | | | | | | | | | 459 | | | | | 355 | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | (2 | ) | | | (6 | ) | | | (5 | ) | | | (1 | ) | | | | (8 | ) | | | | | | | | | (2 | ) | | | | (8 | ) | |
Amortization of DAC and VOBA | | | | 5 | | | | 4 | | | | 3 | | | | 3 | | | | | 4 | | | | | | | | | | 5 | | | | | 4 | | |
Interest expense | | | | 2 | | | | — | | | | 1 | | | | — | | | | | 2 | | | | | | | | | | 2 | | | | | 2 | | |
Other expenses | | | | 105 | | | | 122 | | | | 128 | | | | 129 | | | | | 124 | | | | | | | | | | 105 | | | | | 124 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 1,448 | | | | 1,769 | | | | 1,709 | | | | 1,992 | | | | | 1,839 | | | | | | | | | | 1,448 | | | | | 1,839 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 96 | | | | 235 | | | | 208 | | | | 285 | | | | | 351 | | | | | | | | | | 96 | | | | | 351 | | |
Provision for income tax expense (benefit) | | | | 31 | | | | 80 | | | | 68 | | | | 94 | | | | | 123 | | | | | | | | | | 31 | | | | | 123 | | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | 65 | | | | 155 | | | | 140 | | | | 191 | | | | | 228 | | | | | | | | | | 65 | | | | | 228 | | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 65 | | | $ | 155 | | | $ | 140 | | | $ | 191 | | | | $ | 228 | | | | | | | | | $ | 65 | | | | $ | 228 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 65 | | | $ | 155 | | | $ | 140 | | | $ | 191 | | | | $ | 228 | | | | | | | | | $ | 65 | | | | $ | 228 | | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | (809 | ) | | | (821 | ) | | | (417 | ) | | | (213 | ) | | | | (5 | ) | | | | | | | | | (809 | ) | | | | (5 | ) | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | 39 | | | | 45 | | | | 58 | | | | 52 | | | | | 51 | | | | | | | | | | 39 | | | | | 51 | | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | (2 | ) | | | (1 | ) | | | (2 | ) | | | (2 | ) | | | | (1 | ) | | | | | | | | | (2 | ) | | | | (1 | ) | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | (1 | ) | | | (28 | ) | | | (40 | ) | | | — | | | | | (4 | ) | | | | | | | | | (1 | ) | | | | (4 | ) | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | 1 | | | | 1 | | | | 1 | | | | 1 | | | | | 3 | | | | | | | | | | 1 | | | | | 3 | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | — | | | | — | | | | — | | | | 1 | | | | | 1 | | | | | | | | | | — | | | | | 1 | | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | 268 | | | | 282 | | | | 141 | | | | 54 | | | | | (17 | ) | | | | | | | | | 268 | | | | | (17 | ) | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | (439 | ) | | | (367 | ) | | | (119 | ) | | | 84 | | | | | 256 | | | | | | | | | | (439 | ) | | | | 256 | | |
Income (loss) from discontinued operations, net of income tax | | | | 1 | | | | 1 | | | | 1 | | | | 4 | | | | | 1 | | | | | | | | | | 1 | | | | | 1 | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | (438 | ) | | | (366 | ) | | | (118 | ) | | | 88 | | | | | 257 | | | | | | | | | | (438 | ) | | | | 257 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | — | | | | — | | | | — | | | | 1 | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | (438 | ) | | | (366 | ) | | | (118 | ) | | | 87 | | | | | 257 | | | | | | | | | | (438 | ) | | | | 257 | | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | (438 | ) | | $ | (366 | ) | | $ | (118 | ) | | $ | 87 | | | | $ | 257 | | | | | | | | | $ | (438 | ) | | | $ | 257 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 433 | | | $ | 825 | | | $ | 707 | | | $ | 1,011 | | | | $ | 920 | | | | | | | | | $ | 433 | | | | $ | 920 | | |
| | | | | | | | | | | | | | | | | | |
21
U.S. BUSINESS
CORPORATE BENEFIT FUNDING
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES; AND SEPARATE ACCOUNT LIABILITIES
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | |
| | | For the Three Months Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
Balance, beginning of period | | | $ | 107,091 | | | $ | 101,662 | | | $ | 99,652 | | | $ | 97,897 | | | | $ | 97,170 | | |
Premiums and deposits | | | | 13,215 | | | | 16,393 | | | | 10,427 | | | | 9,836 | | | | | 11,720 | | |
Surrenders and withdrawals | | | | (18,277 | ) | | | (18,009 | ) | | | (12,532 | ) | | | (10,466 | ) | | | | (8,856 | ) | |
Benefit payments | | | | (770 | ) | | | (769 | ) | | | (820 | ) | | | (800 | ) | | | | (806 | ) | |
| | | | | | | |
Net Flows | | | | (5,832 | ) | | | (2,385 | ) | | | (2,925 | ) | | | (1,430 | ) | | | | 2,058 | | |
Net transfers from (to) separate account | | | | (13 | ) | | | (17 | ) | | | (16 | ) | | | 58 | | | | | 16 | | |
Interest | | | | 1,139 | | | | 1,083 | | | | 1,044 | | | | 1,049 | | | | | 1,036 | | |
Policy charges | | | | (29 | ) | | | (36 | ) | | | (30 | ) | | | (20 | ) | | | | (31 | ) | |
Other | | | | (694 | ) | | | (655 | ) | | | 172 | | | | (384 | ) | | | | (62 | ) | |
| | | | | | | |
Balance, end of period | | | $ | 101,662 | | | $ | 99,652 | | | $ | 97,897 | | | $ | 97,170 | | | | $ | 100,187 | | |
| | | | | | | |
SEPARATE ACCOUNT LIABILITIES
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | |
| | | For the Three Months Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
Balance, beginning of period | | | $ | 45,814 | | | $ | 42,726 | | | $ | 42,293 | | | $ | 46,015 | | | | $ | 45,732 | | |
Premiums and deposits | | | | 1,655 | | | | 631 | | | | 1,931 | | | | 1,748 | | | | | 2,061 | | |
Surrenders and withdrawals | | | | (1,883 | ) | | | (1,099 | ) | | | (1,177 | ) | | | (1,360 | ) | | | | (1,501 | ) | |
Benefit payments | | | | (10 | ) | | | (13 | ) | | | (10 | ) | | | (11 | ) | | | | (11 | ) | |
| | | | | | | |
Net Flows | | | | (238 | ) | | | (481 | ) | | | 744 | | | | 377 | | | | | 549 | | |
Investment Performance | | | | (985 | ) | | | 1,590 | | | | 2,703 | | | | 384 | | | | | 1,049 | | |
Net transfers from (to) general account | | | | 13 | | | | 17 | | | | 16 | | | | (58 | ) | | | | (16 | ) | |
Policy charges | | | | (59 | ) | | | (57 | ) | | | (55 | ) | | | (57 | ) | | | | (61 | ) | |
Other | | | | (1,819 | ) | | | (1,502 | ) | | | 314 | | | | (929 | ) | | | | 1,577 | | |
| | | | | | | |
Balance, end of period | | | $ | 42,726 | | | $ | 42,293 | | | $ | 46,015 | | | $ | 45,732 | | | | $ | 48,830 | | |
| | | | | | | |
22
U.S. BUSINESS
CORPORATE BENEFIT FUNDING
OTHER EXPENSES BY MAJOR CATEGORY
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | |
| | | For the Three Months Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Direct and allocated expenses | | | $ | 64 | | | $ | 69 | | | $ | 63 | | | $ | 65 | | | | $ | 55 | | |
Pension and other post-retirement benefit costs | | | | 10 | | | | 16 | | | | 15 | | | | 15 | | | | | 11 | | |
Premium taxes, other taxes, and licenses and fees | | | | 1 | | | | 6 | | | | 12 | | | | 5 | | | | | 3 | | |
| | | | | | | |
Total fixed operating expenses | | | $ | 75 | | | $ | 91 | | | $ | 90 | | | $ | 85 | | | | $ | 69 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Commissions and other variable expenses | | | | 30 | | | | 31 | | | | 38 | | | | 44 | | | | | 55 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Total other expenses | | | $ | 105 | | | $ | 122 | | | $ | 128 | | | $ | 129 | | | | $ | 124 | | |
| | | | | | | |
23
U.S. BUSINESS
CORPORATE BENEFIT FUNDING
SPREAD
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | |
CORPORATE BENEFIT FUNDING | | | For the Three Months Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Investment income yield | | | | 4.06 | % | | | 4.52 | % | | | 4.71 | % | | | 4.96 | % | | | | 5.04 | % | |
Average crediting rate | | | | 4.20 | % | | | 4.15 | % | | | 4.14 | % | | | 4.13 | % | | | | 4.00 | % | |
| | | | | | | |
Annualized general account spread | | | | (0.14 | %) | | | 0.37 | % | | | 0.57 | % | | | 0.83 | % | | | | 1.04 | % | |
| | | | | | | |
24
U.S. BUSINESS
AUTO & HOME
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums (1) | | | $ | 722 | | | $ | 726 | | | $ | 727 | | | $ | 727 | | | | $ | 714 | | | | | | | | | $ | 722 | | | | $ | 714 | | |
Universal life and investment-type product policy fees | | | �� | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income | | | | 40 | | | | 49 | | | | 45 | | | | 46 | | | | | 53 | | | | | | | | | | 40 | | | | | 53 | | |
Other revenues | | | | 9 | | | | 5 | | | | 8 | | | | 11 | | | | | (2 | ) | | | | | | | | | 9 | | | | | (2 | ) | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | 771 | | | | 780 | | | | 780 | | | | 784 | | | | | 765 | | | | | | | | | | 771 | | | | | 765 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends (1) | | | | 479 | | | | 492 | | | | 483 | | | | 478 | | | | | 494 | | | | | | | | | | 479 | | | | | 494 | | |
Interest credited to policyholder account balances | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | (104 | ) | | | (113 | ) | | | (112 | ) | | | (106 | ) | | | | (104 | ) | | | | | | | | | (104 | ) | | | | (104 | ) | |
Amortization of DAC and VOBA | | | | 110 | | | | 111 | | | | 107 | | | | 108 | | | | | 107 | | | | | | | | | | 110 | | | | | 107 | | |
Interest expense | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses | | | | 187 | | | | 194 | | | | 189 | | | | 194 | | | | | 179 | | | | | | | | | | 187 | | | | | 179 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 672 | | | | 684 | | | | 667 | | | | 674 | | | | | 676 | | | | | | | | | | 672 | | | | | 676 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 99 | | | | 96 | | | | 113 | | | | 110 | | | | | 89 | | | | | | | | | | 99 | | | | | 89 | | |
Provision for income tax expense (benefit) | | | | 23 | | | | 20 | | | | 27 | | | | 26 | | | | | 17 | | | | | | | | | | 23 | | | | | 17 | | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | 76 | | | | 76 | | | | 86 | | | | 84 | | | | | 72 | | | | | | | | | | 76 | | | | | 72 | | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 76 | | | $ | 76 | | | $ | 86 | | | $ | 84 | | | | $ | 72 | | | | | | | | | $ | 76 | | | | $ | 72 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 76 | | | $ | 76 | | | $ | 86 | | | $ | 84 | | | | $ | 72 | | | | | | | | | $ | 76 | | | | $ | 72 | | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | 31 | | | | (8 | ) | | | (30 | ) | | | 5 | | | | | (1 | ) | | | | | | | | | 31 | | | | | (1 | ) | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | (11 | ) | | | 3 | | | | 11 | | | | (2 | ) | | | | — | | | | | | | | | | (11 | ) | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | 96 | | | | 71 | | | | 67 | | | | 87 | | | | | 71 | | | | | | | | | | 96 | | | | | 71 | | |
Income (loss) from discontinued operations, net of income tax | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | 96 | | | | 71 | | | | 67 | | | | 87 | | | | | 71 | | | | | | | | | | 96 | | | | | 71 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | 96 | | | | 71 | | | | 67 | | | | 87 | | | | | 71 | | | | | | | | | | 96 | | | | | 71 | | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | 96 | | | $ | 71 | | | $ | 67 | | | $ | 87 | | | | $ | 71 | | | | | | | | | $ | 96 | | | | $ | 71 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 731 | | | $ | 731 | | | $ | 735 | | | $ | 738 | | | | $ | 712 | | | | | | | | | $ | 731 | | | | $ | 712 | | |
| | | | | | | | | | | | | | | | | | |
| | |
(1) | | Premiums reflect earned premiums and policyholder benefits and dividends includes losses and loss adjustment expense. |
25
U.S. BUSINESS
AUTO & HOME — AUTO
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS — PRODUCT LEVEL
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums (1) | | | $ | 497 | | | $ | 499 | | | $ | 500 | | | $ | 495 | | | | $ | 484 | | | | | | | | | $ | 497 | | | | $ | 484 | | |
Universal life and investment-type product policy fees | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income | | | | 25 | | | | 30 | | | | 28 | | | | 29 | | | | | 34 | | | | | | | | | | 25 | | | | | 34 | | |
Other revenues | | | | 5 | | | | 3 | | | | 5 | | | | 4 | | | | | 4 | | | | | | | | | | 5 | | | | | 4 | | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | 527 | | | | 532 | | | | 533 | | | | 528 | | | | | 522 | | | | | | | | | | 527 | | | | | 522 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends (1) | | | | 316 | | | | 350 | | | | 353 | | | | 373 | | | | | 336 | | | | | | | | | | 316 | | | | | 336 | | |
Interest credited to policyholder account balances | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | (70 | ) | | | (75 | ) | | | (77 | ) | | | (65 | ) | | | | (68 | ) | | | | | | | | | (70 | ) | | | | (68 | ) | |
Amortization of DAC and VOBA | | | | 70 | | | | 75 | | | | 74 | | | | 68 | | | | | 69 | | | | | | | | | | 70 | | | | | 69 | | |
Interest expense | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses | | | | 129 | | | | 124 | | | | 124 | | | | 128 | | | | | 120 | | | | | | | | | | 129 | | | | | 120 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 445 | | | | 474 | | | | 474 | | | | 504 | | | | | 457 | | | | | | | | | | 445 | | | | | 457 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 82 | | | | 58 | | | | 59 | | | | 24 | | | | | 65 | | | | | | | | | | 82 | | | | | 65 | | |
Provision for income tax expense (benefit) | | | | 20 | | | | 13 | | | | 13 | | | | — | | | | | 13 | | | | | | | | | | 20 | | | | | 13 | | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | 62 | | | | 45 | | | | 46 | | | | 24 | | | | | 52 | | | | | | | | | | 62 | | | | | 52 | | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 62 | | | $ | 45 | | | $ | 46 | | | $ | 24 | | | | $ | 52 | | | | | | | | | $ | 62 | | | | $ | 52 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 62 | | | $ | 45 | | | $ | 46 | | | $ | 24 | | | | $ | 52 | | | | | | | | | $ | 62 | | | | $ | 52 | | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | 19 | | | | (5 | ) | | | (18 | ) | | | 2 | | | | | (1 | ) | | | | | | | | | 19 | | | | | (1 | ) | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | (7 | ) | | | 2 | | | | 7 | | | | (1 | ) | | | | — | | | | | | | | | | (7 | ) | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | 74 | | | | 42 | | | | 35 | | | | 25 | | | | | 51 | | | | | | | | | | 74 | | | | | 51 | | |
Income (loss) from discontinued operations, net of income tax | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | 74 | | | | 42 | | | | 35 | | | | 25 | | | | | 51 | | | | | | | | | | 74 | | | | | 51 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | 74 | | | | 42 | | | | 35 | | | | 25 | | | | | 51 | | | | | | | | | | 74 | | | | | 51 | | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | 74 | | | $ | 42 | | | $ | 35 | | | $ | 25 | | | | $ | 51 | | | | | | | | | $ | 74 | | | | $ | 51 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 502 | | | $ | 502 | | | $ | 505 | | | $ | 499 | | | | $ | 488 | | | | | | | | | $ | 502 | | | | $ | 488 | | |
| | | | | | | | | | | | | | | | | | |
| | |
(1) | | Premiums reflect earned premiums and policyholder benefits and dividends includes losses and loss adjustment expense. |
26
U.S. BUSINESS
AUTO & HOME — HOMEOWNERS & OTHER
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS — PRODUCT LEVEL
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums (1) | | | $ | 225 | | | $ | 227 | | | $ | 227 | | | $ | 232 | | | | $ | 230 | | | | | | | | | $ | 225 | | | | $ | 230 | | |
Universal life and investment-type product policy fees | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income | | | | 15 | | | | 19 | | | | 17 | | | | 17 | | | | | 19 | | | | | | | | | | 15 | | | | | 19 | | |
Other revenues | | | | 4 | | | | 2 | | | | 3 | | | | 7 | | | | | (6 | ) | | | | | | | | | 4 | | | | | (6 | ) | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | 244 | | | | 248 | | | | 247 | | | | 256 | | | | | 243 | | | | | | | | | | 244 | | | | | 243 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends (1) | | | | 163 | | | | 142 | | | | 130 | | | | 105 | | | | | 158 | | | | | | | | | | 163 | | | | | 158 | | |
Interest credited to policyholder account balances | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | (34 | ) | | | (38 | ) | | | (35 | ) | | | (41 | ) | | | | (36 | ) | | | | | | | | | (34 | ) | | | | (36 | ) | |
Amortization of DAC and VOBA | | | | 40 | | | | 36 | | | | 33 | | | | 40 | | | | | 38 | | | | | | | | | | 40 | | | | | 38 | | |
Interest expense | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses | | | | 58 | | | | 70 | | | | 65 | | | | 66 | | | | | 59 | | | | | | | | | | 58 | | | | | 59 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 227 | | | | 210 | | | | 193 | | | | 170 | | | | | 219 | | | | | | | | | | 227 | | | | | 219 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 17 | | | | 38 | | | | 54 | | | | 86 | | | | | 24 | | | | | | | | | | 17 | | | | | 24 | | |
Provision for income tax expense (benefit) | | | | 3 | | | | 7 | | | | 14 | | | | 26 | | | | | 4 | | | | | | | | | | 3 | | | | | 4 | | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | 14 | | | | 31 | | | | 40 | | | | 60 | | | | | 20 | | | | | | | | | | 14 | | | | | 20 | | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 14 | | | $ | 31 | | | $ | 40 | | | $ | 60 | | | | $ | 20 | | | | | | | | | $ | 14 | | | | $ | 20 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 14 | | | $ | 31 | | | $ | 40 | | | $ | 60 | | | | $ | 20 | | | | | | | | | $ | 14 | | | | $ | 20 | | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | 12 | | | | (3 | ) | | | (12 | ) | | | 3 | | | | | — | | | | | | | | | | 12 | | | | | — | | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | (4 | ) | | | 1 | | | | 4 | | | | (1 | ) | | | | — | | | | | | | | | | (4 | ) | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | 22 | | | | 29 | | | | 32 | | | | 62 | | | | | 20 | | | | | | | | | | 22 | | | | | 20 | | |
Income (loss) from discontinued operations, net of income tax | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | 22 | | | | 29 | | | | 32 | | | | 62 | | | | | 20 | | | | | | | | | | 22 | | | | | 20 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | 22 | | | | 29 | | | | 32 | | | | 62 | | | | | 20 | | | | | | | | | | 22 | | | | | 20 | | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | 22 | | | $ | 29 | | | $ | 32 | | | $ | 62 | | | | $ | 20 | | | | | | | | | $ | 22 | | | | $ | 20 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 229 | | | $ | 229 | | | $ | 230 | | | $ | 239 | | | | $ | 224 | | | | | | | | | $ | 229 | | | | $ | 224 | | |
| | | | | | | | | | | | | | | | | | |
| | |
(1) | | Premiums reflect earned premiums and policyholder benefits and dividends includes losses and loss adjustment expense. |
27
U.S. BUSINESS
AUTO & HOME
WRITTEN PREMIUMS BY PRODUCT AND SELECTED FINANCIAL INFORMATION AND SUPPLEMENTAL DATA
| | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Written Premiums by Product | | | | | | | | | | | | | | | | | | | | | | | |
Automobile | | | $ | 496 | | | $ | 503 | | | $ | 503 | | | $ | 475 | | | | $ | 486 | | |
Homeowners | | | | 182 | | | | 231 | | | | 240 | | | | 212 | | | | | 190 | | |
Other | | | | 21 | | | | 13 | | | | 11 | | | | 11 | | | | | 21 | | |
| | | | | | | |
Total | | | $ | 699 | | | $ | 747 | | | $ | 754 | | | $ | 698 | | | | $ | 697 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Selected Financial Information and Supplemental Data | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Total Auto & Home | | | | | | | | | | | | | | | | | | | | | | | |
Loss and loss adjustment expense ratio | | | | 66.5 | % | | | 67.7 | % | | | 66.1 | % | | | 65.6 | % | | | | 69.5 | % | |
Policyholder benefits and dividends | | | | (0.1 | %) | | | 0.2 | % | | | 0.1 | % | | | 0.1 | % | | | | (0.3 | %) | |
Other expense ratio | | | | 26.7 | % | | | 26.2 | % | | | 25.5 | % | | | 27.2 | % | | | | 25.5 | % | |
Payment fees credit | | | | (0.7 | %) | | | (0.6 | %) | | | (0.6 | %) | | | (0.6 | %) | | | | (0.6 | %) | |
| | | | | | | |
Total combined ratio | | | | 92.4 | % | | | 93.5 | % | | | 91.1 | % | | | 92.3 | % | | | | 94.1 | % | |
Effect of catastrophe losses | | | | 4.3 | % | | | 5.5 | % | | | 3.4 | % | | | 0.5 | % | | | | 5.3 | % | |
| | | | | | | |
Combined ratio excluding catastrophes | | | | 88.1 | % | | | 88.0 | % | | | 87.7 | % | | | 91.8 | % | | | | 88.8 | % | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Auto | | | | | | | | | | | | | | | | | | | | | | | |
Loss and loss adjustment expense ratio | | | | 63.6 | % | | | 69.8 | % | | | 70.2 | % | | | 75.5 | % | | | | 69.8 | % | |
Policyholder benefits and dividends | | | | (0.1 | %) | | | 0.2 | % | | | 0.1 | % | | | 0.1 | % | | | | (0.3 | %) | |
Other expense ratio | | | | 26.0 | % | | | 25.1 | % | | | 24.4 | % | | | 26.7 | % | | | | 25.0 | % | |
Payment fees credit | | | | (0.8 | %) | | | (0.7 | %) | | | (0.7 | %) | | | (0.7 | %) | | | | (0.7 | %) | |
| | | | | | | |
Total combined ratio | | | | 88.7 | % | | | 94.4 | % | | | 94.0 | % | | | 101.6 | % | | | | 93.8 | % | |
Effect of catastrophe losses | | | | 0.8 | % | | | 0.8 | % | | | 0.4 | % | | | (0.2 | %) | | | | 0.5 | % | |
| | | | | | | |
Combined ratio excluding catastrophes | | | | 87.9 | % | | | 93.6 | % | | | 93.6 | % | | | 101.8 | % | | | | 93.3 | % | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Homeowners & Other | | | | | | | | | | | | | | | | | | | | | | | |
Loss and loss adjustment expense ratio | | | | 72.6 | % | | | 63.3 | % | | | 56.9 | % | | | 44.7 | % | | | | 68.7 | % | |
Policyholder benefits and dividends | | | | (0.1 | %) | | | 0.2 | % | | | 0.2 | % | | | 0.1 | % | | | | (0.3 | %) | |
Other expense ratio | | | | 28.4 | % | | | 28.5 | % | | | 28.0 | % | | | 28.2 | % | | | | 26.7 | % | |
Payment fees credit | | | | (0.5 | %) | | | (0.4 | %) | | | (0.4 | %) | | | (0.4 | %) | | | | (0.4 | %) | |
| | | | | | | |
Total combined ratio | | | | 100.4 | % | | | 91.6 | % | | | 84.7 | % | | | 72.6 | % | | | | 94.7 | % | |
Effect of catastrophe losses | | | | 12.0 | % | | | 15.9 | % | | | 9.7 | % | | | 1.9 | % | | | | 15.3 | % | |
| | | | | | | |
Combined ratio excluding catastrophes | | | | 88.4 | % | | | 75.7 | % | | | 75.0 | % | | | 70.7 | % | | | | 79.4 | % | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Pre-Tax Catastrophe Losses | | | | | | | | | | | | | | | | | | | | | | | |
Auto | | | $ | 4 | | | $ | 4 | | | $ | 2 | | | $ | (1 | ) | | | $ | 3 | | |
Homeowners & Other | | | | 27 | | | | 36 | | | | 22 | | | | 5 | | | | | 35 | | |
| | | | | | | |
Total | | | $ | 31 | | | $ | 40 | | | $ | 24 | | | $ | 4 | | | | $ | 38 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Catastrophe points on combined ratios | | | | 4.3 | | | | 5.5 | | | | 3.4 | | | | 0.5 | | | | | 5.3 | | |
| | | | | | | |
28
INTERNATIONAL
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended | | | | | | | For the Year-to-Date Period Ended |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 721 | | | $ | 777 | | | $ | 868 | | | $ | 821 | | | | $ | 893 | | | | | | | | | $ | 721 | | | | $ | 893 | | |
Universal life and investment-type product policy fees | | | | 210 | | | | 226 | | | | 222 | | | | 403 | | | | | 291 | | | | | | | | | | 210 | | | | | 291 | | |
Net investment income | | | | 168 | | | | 359 | | | | 395 | | | | 271 | | | | | 450 | | | | | | | | | | 168 | | | | | 450 | | |
Other revenues | | | | 2 | | | | 2 | | | | 4 | | | | 6 | | | | | 1 | | | | | | | | | | 2 | | | | | 1 | | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | 1,101 | | | | 1,364 | | | | 1,489 | | | | 1,501 | | | | | 1,635 | | | | | | | | | | 1,101 | | | | | 1,635 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | 548 | | | | 600 | | | | 705 | | | | 807 | | | | | 838 | | | | | | | | | | 548 | | | | | 838 | | |
Interest credited to policyholder account balances | | | | 78 | | | | 159 | | | | 198 | | | | 146 | | | | | 151 | | | | | | | | | | 78 | | | | | 151 | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | (145 | ) | | | (140 | ) | | | (164 | ) | | | (181 | ) | | | | (192 | ) | | | | | | | | | (145 | ) | | | | (192 | ) | |
Amortization of DAC and VOBA | | | | 95 | | | | 98 | | | | 79 | | | | 143 | | | | | 105 | | | | | | | | | | 95 | | | | | 105 | | |
Interest expense | | | | 2 | | | | 1 | | | | 3 | | | | 2 | | | | | 1 | | | | | | | | | | 2 | | | | | 1 | | |
Other expenses | | | | 336 | | | | 436 | | | | 481 | | | | 544 | | | | | 522 | | | | | | | | | | 336 | | | | | 522 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 914 | | | | 1,154 | | | | 1,302 | | | | 1,461 | | | | | 1,425 | | | | | | | | | | 914 | | | | | 1,425 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 187 | | | | 210 | | | | 187 | | | | 40 | | | | | 210 | | | | | | | | | | 187 | | | | | 210 | | |
Provision for income tax expense (benefit) | | | | 56 | | | | 52 | | | | 34 | | | | 19 | | | | | 59 | | | | | | | | | | 56 | | | | | 59 | | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | 131 | | | | 158 | | | | 153 | | | | 21 | | | | | 151 | | | | | | | | | | 131 | | | | | 151 | | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 131 | | | $ | 158 | | | $ | 153 | | | $ | 21 | | | | $ | 151 | | | | | | | | | $ | 131 | | | | $ | 151 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 131 | | | $ | 158 | | | $ | 153 | | | $ | 21 | | | | $ | 151 | | | | | | | | | $ | 131 | | | | $ | 151 | | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | 454 | | | | (501 | ) | | | (574 | ) | | | (282 | ) | | | | (29 | ) | | | | | | | | | 454 | | | | | (29 | ) | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | 5 | | | | (5 | ) | | | (3 | ) | | | (10 | ) | | | | (8 | ) | | | | | | | | | 5 | | | | | (8 | ) | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | 20 | | | | (96 | ) | | | (35 | ) | | | (45 | ) | | | | (5 | ) | | | | | | | | | 20 | | | | | (5 | ) | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | (22 | ) | | | 39 | | | | (24 | ) | | | 2 | | | | | (19 | ) | | | | | | | | | (22 | ) | | | | (19 | ) | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | 1 | | | | (1 | ) | | | — | | | | — | | | | | — | | | | | | | | | | 1 | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | (5 | ) | | | (9 | ) | | | (7 | ) | | | (11 | ) | | | | (3 | ) | | | | | | | | | (5 | ) | | | | (3 | ) | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | (149 | ) | | | 201 | | | | 207 | | | | 107 | | | | | 24 | | | | | | | | | | (149 | ) | | | | 24 | | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | 435 | | | | (214 | ) | | | (283 | ) | | | (218 | ) | | | | 111 | | | | | | | | | | 435 | | | | | 111 | | |
Income (loss) from discontinued operations, net of income tax | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | 435 | | | | (214 | ) | | | (283 | ) | | | (218 | ) | | | | 111 | | | | | | | | | | 435 | | | | | 111 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | (5 | ) | | | (9 | ) | | | (5 | ) | | | (9 | ) | | | | (2 | ) | | | | | | | | | (5 | ) | | | | (2 | ) | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | 440 | | | | (205 | ) | | | (278 | ) | | | (209 | ) | | | | 113 | | | | | | | | | | 440 | | | | | 113 | | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | 440 | | | $ | (205 | ) | | $ | (278 | ) | | $ | (209 | ) | | | $ | 113 | | | | | | | | | $ | 440 | | | | $ | 113 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 933 | | | $ | 1,005 | | | $ | 1,094 | | | $ | 1,230 | | | | $ | 1,185 | | | | | | | | | $ | 933 | | | | $ | 1,185 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Actual Number of Sales Representatives | | | | 5,757 | | | | 5,747 | | | | 5,622 | | | | 6,318 | | | | | 6,102 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
29
INTERNATIONAL — LATIN AMERICA REGION
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | For the Three Months Ended | | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 348 | | | $ | 366 | | | $ | 420 | | | $ | 429 | | | | $ | 454 | | | | | | | | | $ | 348 | | | | $ | 454 | | |
Universal life and investment-type product policy fees | | | | 122 | | | | 136 | | | | 133 | | | | 156 | | | | | 150 | | | | | | | | | | 122 | | | | | 150 | | |
Net investment income | | | | 119 | | | | 191 | | | | 193 | | | | 119 | | | | | 280 | | | | | | | | | | 119 | | | | | 280 | | |
Other revenues | | | | 1 | | | | 1 | | | | 3 | | | | 2 | | | | | 1 | | | | | | | | | | 1 | | | | | 1 | | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | 590 | | | | 694 | | | | 749 | | | | 706 | | | | | 885 | | | | | | | | | | 590 | | | | | 885 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | 265 | | | | 326 | | | | 384 | | | | 438 | | | | | 486 | | | | | | | | | | 265 | | | | | 486 | | |
Interest credited to policyholder account balances | | | | 78 | | | | 81 | | | | 86 | | | | 86 | | | | | 90 | | | | | | | | | | 78 | | | | | 90 | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | (34 | ) | | | (41 | ) | | | (40 | ) | | | (45 | ) | | | | (49 | ) | | | | | | | | | (34 | ) | | | | (49 | ) | |
Amortization of DAC and VOBA | | | | 32 | | | | 34 | | | | 22 | | | | 27 | | | | | 37 | | | | | | | | | | 32 | | | | | 37 | | |
Interest expense | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses | | | | 71 | | | | 177 | | | | 193 | | | | 209 | | | | | 202 | | | | | | | | | | 71 | | | | | 202 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 412 | | | | 577 | | | | 645 | | | | 715 | | | | | 766 | | | | | | | | | | 412 | | | | | 766 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 178 | | | | 117 | | | | 104 | | | | (9 | ) | | | | 119 | | | | | | | | | | 178 | | | | | 119 | | |
Provision for income tax expense (benefit) | | | | 56 | | | | 31 | | | | 23 | | | | 12 | | | | | 34 | | | | | | | | | | 56 | | | | | 34 | | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | 122 | | | | 86 | | | | 81 | | | | (21 | ) | | | | 85 | | | | | | | | | | 122 | | | | | 85 | | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 122 | | | $ | 86 | | | $ | 81 | | | $ | (21 | ) | | | $ | 85 | | | | | | | | | $ | 122 | | | | $ | 85 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 122 | | | $ | 86 | | | $ | 81 | | | $ | (21 | ) | | | $ | 85 | | | | | | | | | $ | 122 | | | | $ | 85 | | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | (17 | ) | | | 23 | | | | (23 | ) | | | 35 | | | | | (13 | ) | | | | | | | | | (17 | ) | | | | (13 | ) | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | 8 | | | | — | | | | 2 | | | | (3 | ) | | | | (1 | ) | | | | | | | | | 8 | | | | | (1 | ) | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | (22 | ) | | | 39 | | | | (24 | ) | | | 2 | | | | | (19 | ) | | | | | | | | | (22 | ) | | | | (19 | ) | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | 3 | | | | (11 | ) | | | 10 | | | | (5 | ) | | | | 13 | | | | | | | | | | 3 | | | | | 13 | | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | 94 | | | | 137 | | | | 46 | | | | 8 | | | | | 65 | | | | | | | | | | 94 | | | | | 65 | | |
Income (loss) from discontinued operations, net of income tax | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | 94 | | | | 137 | | | | 46 | | | | 8 | | | | | 65 | | | | | | | | | | 94 | | | | | 65 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | 94 | | | | 137 | | | | 46 | | | | 8 | | | | | 65 | | | | | | | | | | 94 | | | | | 65 | | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | 94 | | | $ | 137 | | | $ | 46 | | | $ | 8 | | | | $ | 65 | | | | | | | | | $ | 94 | | | | $ | 65 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 471 | | | $ | 503 | | | $ | 556 | | | $ | 587 | | | | $ | 605 | | | | | | | | | $ | 471 | | | | $ | 605 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Actual Number of Sales Representatives | | | | 118 | | | | 120 | | | | 114 | | | | 126 | | | | | 112 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
30
INTERNATIONAL — ASIA PACIFIC REGION
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended | | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 289 | | | $ | 329 | | | $ | 353 | | | $ | 281 | | | | $ | 334 | | | | | | | | | $ | 289 | | | | $ | 334 | | |
Universal life and investment-type product policy fees | | | | 76 | | | | 78 | | | | 78 | | | | 230 | | | | | 120 | | | | | | | | | | 76 | | | | | 120 | | |
Net investment income | | | | 50 | | | | 147 | | | | 126 | | | | 131 | | | | | 117 | | | | | | | | | | 50 | | | | | 117 | | |
Other revenues | | | | — | | | | 1 | | | | — | | | | 1 | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | 415 | | | | 555 | | | | 557 | | | | 643 | | | | | 571 | | | | | | | | | | 415 | | | | | 571 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | 258 | | | | 253 | | | | 292 | | | | 323 | | | | | 308 | | | | | | | | | | 258 | | | | | 308 | | |
Interest credited to policyholder account balances | | | | 6 | | | | 63 | | | | 40 | | | | 41 | | | | | 14 | | | | | | | | | | 6 | | | | | 14 | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | (59 | ) | | | (75 | ) | | | (88 | ) | | | (90 | ) | | | | (92 | ) | | | | | | | | | (59 | ) | | | | (92 | ) | |
Amortization of DAC and VOBA | | | | 52 | | | | 52 | | | | 49 | | | | 105 | | | | | 56 | | | | | | | | | | 52 | | | | | 56 | | |
Interest expense | | | | 1 | | | | — | | | | 2 | | | | 1 | | | | | — | | | | | | | | | | 1 | | | | | — | | |
Other expenses | | | | 134 | | | | 154 | | | | 167 | | | | 185 | | | | | 185 | | | | | | | | | | 134 | | | | | 185 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 392 | | | | 447 | | | | 462 | | | | 565 | | | | | 471 | | | | | | | | | | 392 | | | | | 471 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 23 | | | | 108 | | | | 95 | | | | 78 | | | | | 100 | | | | | | | | | | 23 | | | | | 100 | | |
Provision for income tax expense (benefit) | | | | 2 | | | | 22 | | | | 13 | | | | 13 | | | | | 26 | | | | | | | | | | 2 | | | | | 26 | | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | 21 | | | | 86 | | | | 82 | | | | 65 | | | | | 74 | | | | | | | | | | 21 | | | | | 74 | | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 21 | | | $ | 86 | | | $ | 82 | | | $ | 65 | | | | $ | 74 | | | | | | | | | $ | 21 | | | | $ | 74 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 21 | | | $ | 86 | | | $ | 82 | | | $ | 65 | | | | $ | 74 | | | | | | | | | $ | 21 | | | | $ | 74 | | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | 469 | | | | (527 | ) | | | (555 | ) | | | (316 | ) | | | | 26 | | | | | | | | | | 469 | | | | | 26 | | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | (3 | ) | | | (5 | ) | | | (5 | ) | | | (7 | ) | | | | (7 | ) | | | | | | | | | (3 | ) | | | | (7 | ) | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | 20 | | | | (96 | ) | | | (35 | ) | | | (45 | ) | | | | (5 | ) | | | | | | | | | 20 | | | | | (5 | ) | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | 1 | | | | (1 | ) | | | — | | | | — | | | | | — | | | | | | | | | | 1 | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | (152 | ) | | | 213 | | | | 198 | | | | 112 | | | | | 10 | | | | | | | | | | (152 | ) | | | | 10 | | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | 356 | | | | (330 | ) | | | (315 | ) | | | (191 | ) | | | | 98 | | | | | | | | | | 356 | | | | | 98 | | |
Income (loss) from discontinued operations, net of income tax | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | 356 | | | | (330 | ) | | | (315 | ) | | | (191 | ) | | | | 98 | | | | | | | | | | 356 | | | | | 98 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | 356 | | | | (330 | ) | | | (315 | ) | | | (191 | ) | | | | 98 | | | | | | | | | | 356 | | | | | 98 | | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | 356 | | | $ | (330 | ) | | $ | (315 | ) | | $ | (191 | ) | | | $ | 98 | | | | | | | | | $ | 356 | | | | $ | 98 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 365 | | | $ | 408 | | | $ | 431 | | | $ | 512 | | | | $ | 454 | | | | | | | | | $ | 365 | | | | $ | 454 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Actual Number of Sales Representatives | | | | 5,639 | | | | 5,627 | | | | 5,508 | | | | 6,192 | | | | | 5,990 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
31
INTERNATIONAL — EUROPE/MIDDLE EAST/INDIA REGION
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended | | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 84 | | | $ | 82 | | | $ | 95 | | | $ | 111 | | | | $ | 105 | | | | | | | | | $ | 84 | | | | $ | 105 | | |
Universal life and investment-type product policy fees | | | | 12 | | | | 12 | | | | 11 | | | | 17 | | | | | 21 | | | | | | | | | | 12 | | | | | 21 | | |
Net investment income | | | | (1 | ) | | | 21 | | | | 76 | | | | 21 | | | | | 53 | | | | | | | | | | (1 | ) | | | | 53 | | |
Other revenues | | | | 1 | | | | — | | | | 1 | | | | 3 | | | | | — | | | | | | | | | | 1 | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | 96 | | | | 115 | | | | 183 | | | | 152 | | | | | 179 | | | | | | | | | | 96 | | | | | 179 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | 25 | | | | 21 | | | | 29 | | | | 46 | | | | | 44 | | | | | | | | | | 25 | | | | | 44 | | |
Interest credited to policyholder account balances | | | | (6 | ) | | | 15 | | | | 72 | | | | 19 | | | | | 47 | | | | | | | | | | (6 | ) | | | | 47 | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | (52 | ) | | | (24 | ) | | | (36 | ) | | | (46 | ) | | | | (51 | ) | | | | | | | | | (52 | ) | | | | (51 | ) | |
Amortization of DAC and VOBA | | | | 11 | | | | 12 | | | | 8 | | | | 11 | | | | | 12 | | | | | | | | | | 11 | | | | | 12 | | |
Interest expense | | | | 1 | | | | 1 | | | | 1 | | | | 1 | | | | | 1 | | | | | | | | | | 1 | | | | | 1 | | |
Other expenses | | | | 131 | | | | 105 | | | | 121 | | | | 150 | | | | | 135 | | | | | | | | | | 131 | | | | | 135 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 110 | | | | 130 | | | | 195 | | | | 181 | | | | | 188 | | | | | | | | | | 110 | | | | | 188 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | (14 | ) | | | (15 | ) | | | (12 | ) | | | (29 | ) | | | | (9 | ) | | | | | | | | | (14 | ) | | | | (9 | ) | |
Provision for income tax expense (benefit) | | | | (2 | ) | | | (1 | ) | | | (2 | ) | | | (6 | ) | | | | (1 | ) | | | | | | | | | (2 | ) | | | | (1 | ) | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | (12 | ) | | | (14 | ) | | | (10 | ) | | | (23 | ) | | | | (8 | ) | | | | | | | | | (12 | ) | | | | (8 | ) | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | (12 | ) | | $ | (14 | ) | | $ | (10 | ) | | $ | (23 | ) | | | $ | (8 | ) | | | | | | | | $ | (12 | ) | | | $ | (8 | ) | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | (12 | ) | | $ | (14 | ) | | $ | (10 | ) | | $ | (23 | ) | | | $ | (8 | ) | | | | | | | | $ | (12 | ) | | | $ | (8 | ) | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | 2 | | | | 3 | | | | 4 | | | | (1 | ) | | | | (42 | ) | | | | | | | | | 2 | | | | | (42 | ) | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | (5 | ) | | | (9 | ) | | | (7 | ) | | | (11 | ) | | | | (3 | ) | | | | | | | | | (5 | ) | | | | (3 | ) | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | — | | | | (1 | ) | | | (1 | ) | | | — | | | | | 1 | | | | | | | | | | — | | | | | 1 | | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | (15 | ) | | | (21 | ) | | | (14 | ) | | | (35 | ) | | | | (52 | ) | | | | | | | | | (15 | ) | | | | (52 | ) | |
Income (loss) from discontinued operations, net of income tax | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | (15 | ) | | | (21 | ) | | | (14 | ) | | | (35 | ) | | | | (52 | ) | | | | | | | | | (15 | ) | | | | (52 | ) | |
Less: Net income (loss) attributable to noncontrolling interest | | | | (5 | ) | | | (9 | ) | | | (5 | ) | | | (9 | ) | | | | (2 | ) | | | | | | | | | (5 | ) | | | | (2 | ) | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | (10 | ) | | | (12 | ) | | | (9 | ) | | | (26 | ) | | | | (50 | ) | | | | | | | | | (10 | ) | | | | (50 | ) | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | (10 | ) | | $ | (12 | ) | | $ | (9 | ) | | $ | (26 | ) | | | $ | (50 | ) | | | | | | | | $ | (10 | ) | | | $ | (50 | ) | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 97 | | | $ | 94 | | | $ | 107 | | | $ | 131 | | | | $ | 126 | | | | | | | | | $ | 97 | | | | $ | 126 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Actual Number of Sales Representatives | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
32
BANKING, CORPORATE & OTHER
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended | | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | �� | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 2 | | | $ | 4 | | | $ | 5 | | | $ | 8 | | | | $ | — | | | | | | | | | $ | 2 | | | | $ | — | | |
Universal life and investment-type product policy fees | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income | | | | 51 | | | | 135 | | | | 120 | | | | 171 | | | | | 243 | | | | | | | | | | 51 | | | | | 243 | | |
Other revenues | | | | 267 | | | | 281 | | | | 274 | | | | 270 | | | | | 213 | | | | | | | | | | 267 | | | | | 213 | | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | 320 | | | | 420 | | | | 399 | | | | 449 | | | | | 456 | | | | | | | | | | 320 | | | | | 456 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | — | | | | 3 | | | | — | | | | 1 | | | | | (5 | ) | | | | | | | | | — | | | | | (5 | ) | |
Interest credited to policyholder account balances | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to bank deposits | | | | 43 | | | | 40 | | | | 37 | | | | 43 | | | | | 39 | | | | | | | | | | 43 | | | | | 39 | | |
Capitalization of DAC | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of DAC and VOBA | | | | — | | | | 2 | | | | — | | | | 1 | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense | | | | 240 | | | | 252 | | | | 270 | | | | 265 | | | | | 261 | | | | | | | | | | 240 | | | | | 261 | | |
Other expenses | | | | 287 | | | | 331 | | | | 297 | | | | 421 | | | | | 274 | | | | | | | | | | 287 | | | | | 274 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 570 | | | | 628 | | | | 604 | | | | 731 | | | | | 569 | | | | | | | | | | 570 | | | | | 569 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | (250 | ) | | | (208 | ) | | | (205 | ) | | | (282 | ) | | | | (113 | ) | | | | | | | | | (250 | ) | | | | (113 | ) | |
Provision for income tax expense (benefit) | | | | (102 | ) | | | (145 | ) | | | (167 | ) | | | (203 | ) | | | | (69 | ) | | | | | | | | | (102 | ) | | | | (69 | ) | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | (148 | ) | | | (63 | ) | | | (38 | ) | | | (79 | ) | | | | (44 | ) | | | | | | | | | (148 | ) | | | | (44 | ) | |
Preferred stock dividends | | | | 30 | | | | 31 | | | | 30 | | | | 31 | | | | | 30 | | | | | | | | | | 30 | | | | | 30 | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | (178 | ) | | $ | (94 | ) | | $ | (68 | ) | | $ | (110 | ) | | | $ | (74 | ) | | | | | | | | $ | (178 | ) | | | $ | (74 | ) | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | (148 | ) | | $ | (63 | ) | | $ | (38 | ) | | $ | (79 | ) | | | $ | (44 | ) | | | | | | | | $ | (148 | ) | | | $ | (44 | ) | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | 304 | | | | (501 | ) | | | (517 | ) | | | (29 | ) | | | | (27 | ) | | | | | | | | | 304 | | | | | (27 | ) | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | (1 | ) | | | 2 | | | | 12 | | | | 9 | | | | | 8 | | | | | | | | | | (1 | ) | | | | 8 | | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | 106 | | | | | | | | | | — | | | | | 106 | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | (106 | ) | | | | | | | | | — | | | | | (106 | ) | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | 2 | | | | (11 | ) | | | — | | | | 2 | | | | | 1 | | | | | | | | | | 2 | | | | | 1 | | |
Business combination costs | | | | (11 | ) | | | — | | | | (22 | ) | | | 2 | | | | | (29 | ) | | | | | | | | | (11 | ) | | | | (29 | ) | |
Provision for income tax expense (benefit) | | | | (108 | ) | | | 186 | | | | 187 | | | | 89 | | | | | 17 | | | | | | | | | | (108 | ) | | | | 17 | | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | 38 | | | | (387 | ) | | | (378 | ) | | | (6 | ) | | | | (74 | ) | | | | | | | | | 38 | | | | | (74 | ) | |
Income (loss) from discontinued operations, net of income tax | | | | 12 | | | | — | | | | (2 | ) | | | (4 | ) | | | | — | | | | | | | | | | 12 | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | 50 | | | | (387 | ) | | | (380 | ) | | | (10 | ) | | | | (74 | ) | | | | | | | | | 50 | | | | | (74 | ) | |
Less: Net income (loss) attributable to noncontrolling interest | | | | 1 | | | | (7 | ) | | | — | | | | 1 | | | | | 1 | | | | | | | | | | 1 | | | | | 1 | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | 49 | | | | (380 | ) | | | (380 | ) | | | (11 | ) | | | | (75 | ) | | | | | | | | | 49 | | | | | (75 | ) | |
Less: Preferred stock dividends | | | | 30 | | | | 31 | | | | 30 | | | | 31 | | | | | 30 | | | | | | | | | | 30 | | | | | 30 | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | 19 | | | $ | (411 | ) | | $ | (410 | ) | | $ | (42 | ) | | | $ | (105 | ) | | | | | | | | $ | 19 | | | | $ | (105 | ) | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 269 | | | $ | 285 | | | $ | 279 | | | $ | 278 | | | | $ | 213 | | | | | | | | | $ | 269 | | | | $ | 213 | | |
| | | | | | | | | | | | | | | | | | |
33
BANKING, CORPORATE & OTHER — BANKING
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended | | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | | $ | — | | | | | | | | | $ | — | | | | $ | — | | |
Universal life and investment-type product policy fees | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income | | | | 121 | | | | 129 | | | | 115 | | | | 119 | | | | | 108 | | | | | | | | | | 121 | | | | | 108 | | |
Other revenues | | | | 255 | | | | 271 | | | | 264 | | | | 258 | | | | | 191 | | | | | | | | | | 255 | | | | | 191 | | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | 376 | | | | 400 | | | | 379 | | | | 377 | | | | | 299 | | | | | | | | | | 376 | | | | | 299 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to policyholder account balances | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to bank deposits | | | | 43 | | | | 40 | | | | 37 | | | | 43 | | | | | 39 | | | | | | | | | | 43 | | | | | 39 | | |
Capitalization of DAC | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of DAC and VOBA | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense | | | | 13 | | | | 14 | | | | 16 | | | | 13 | | | | | 12 | | | | | | | | | | 13 | | | | | 12 | | |
Other expenses | | | | 202 | | | | 229 | | | | 178 | | | | 214 | | | | | 160 | | | | | | | | | | 202 | | | | | 160 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 258 | | | | 283 | | | | 231 | | | | 270 | | | | | 211 | | | | | | | | | | 258 | | | | | 211 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | 118 | | | | 117 | | | | 148 | | | | 107 | | | | | 88 | | | | | | | | | | 118 | | | | | 88 | | |
Provision for income tax expense (benefit) | | | | 41 | | | | 41 | | | | 68 | | | | 42 | | | | | 35 | | | | | | | | | | 41 | | | | | 35 | | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | 77 | | | | 76 | | | | 80 | | | | 65 | | | | | 53 | | | | | | | | | | 77 | | | | | 53 | | |
Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | 77 | | | $ | 76 | | | $ | 80 | | | $ | 65 | | | | $ | 53 | | | | | | | | | $ | 77 | | | | $ | 53 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | 77 | | | $ | 76 | | | $ | 80 | | | $ | 65 | | | | $ | 53 | | | | | | | | | $ | 77 | | | | $ | 53 | | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | (55 | ) | | | (15 | ) | | | (42 | ) | | | (18 | ) | | | | (12 | ) | | | | | | | | | (55 | ) | | | | (12 | ) | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | 1 | | | | — | | | | 1 | | | | | — | | | | | | | | | | — | | | | | — | | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | — | | | | 1 | | | | — | | | | 1 | | | | | — | | | | | | | | | | — | | | | | — | | |
Business combination costs | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Provision for income tax expense (benefit) | | | | 19 | | | | 5 | | | | 19 | | | | 8 | | | | | 5 | | | | | | | | | | 19 | | | | | 5 | | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | 41 | | | | 68 | | | | 57 | | | | 57 | | | | | 46 | | | | | | | | | | 41 | | | | | 46 | | |
Income (loss) from discontinued operations, net of income tax | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | 41 | | | | 68 | | | | 57 | | | | 57 | | | | | 46 | | | | | | | | | | 41 | | | | | 46 | | |
Less: Net income (loss) attributable to noncontrolling interest | | | | — | | | | 1 | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | 41 | | | | 67 | | | | 57 | | | | 57 | | | | | 46 | | | | | | | | | | 41 | | | | | 46 | | |
Less: Preferred stock dividends | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | 41 | | | $ | 67 | | | $ | 57 | | | $ | 57 | | | | $ | 46 | | | | | | | | | $ | 41 | | | | $ | 46 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 255 | | | $ | 271 | | | $ | 264 | | | $ | 258 | | | | $ | 191 | | | | | | | | | $ | 255 | | | | $ | 191 | | |
| | | | | | | | | | | | | | | | | | |
34
BANKING, CORPORATE & OTHER — CORPORATE & OTHER
STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended | | | | | | | | For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums | | | $ | 2 | | | $ | 4 | | | $ | 5 | | | $ | 8 | | | | $ | — | | | | | | | | | $ | 2 | | | | $ | — | | |
Universal life and investment-type product policy fees | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income | | | | (70 | ) | | | 6 | | | | 5 | | | | 52 | | | | | 135 | | | | | | | | | | (70 | ) | | | | 135 | | |
Other revenues | | | | 12 | | | | 10 | | | | 10 | | | | 12 | | | | | 22 | | | | | | | | | | 12 | | | | | 22 | | |
| | | | | | | | | | | | | | | | | | |
Total operating revenues | | | | (56 | ) | | | 20 | | | | 20 | | | | 72 | | | | | 157 | | | | | | | | | | (56 | ) | | | | 157 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and dividends | | | | — | | | | 3 | | | | — | | | | 1 | | | | | (5 | ) | | | | | | | | | — | | | | | (5 | ) | |
Interest credited to policyholder account balances | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to bank deposits | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Capitalization of DAC | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of DAC and VOBA | | | | — | | | | 2 | | | | — | | | | 1 | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense | | | | 227 | | | | 238 | | | | 254 | | | | 252 | | | | | 249 | | | | | | | | | | 227 | | | | | 249 | | |
Other expenses | | | | 85 | | | | 102 | | | | 119 | | | | 207 | | | | | 114 | | | | | | | | | | 85 | | | | | 114 | | |
| | | | | | | | | | | | | | | | | | |
Total operating expenses | | | | 312 | | | | 345 | | | | 373 | | | | 461 | | | | | 358 | | | | | | | | | | 312 | | | | | 358 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings before provision for income tax | | | | (368 | ) | | | (325 | ) | | | (353 | ) | | | (389 | ) | | | | (201 | ) | | | | | | | | | (368 | ) | | | | (201 | ) | |
Provision for income tax expense (benefit) | | | | (143 | ) | | | (186 | ) | | | (235 | ) | | | (245 | ) | | | | (104 | ) | | | | | | | | | (143 | ) | | | | (104 | ) | |
| | | | | | | | | | | | | | | | | | |
Operating earnings | | | | (225 | ) | | | (139 | ) | | | (118 | ) | | | (144 | ) | | | | (97 | ) | | | | | | | | | (225 | ) | | | | (97 | ) | |
Preferred stock dividends | | | | 30 | | | | 31 | | | | 30 | | | | 31 | | | | | 30 | | | | | | | | | | 30 | | | | | 30 | | |
| | | | | | | | | | | | | | | | | | |
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | | | $ | (255 | ) | | $ | (170 | ) | | $ | (148 | ) | | $ | (175 | ) | | | $ | (127 | ) | | | | | | | | $ | (255 | ) | | | $ | (127 | ) | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Income Reconciliation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating earnings | | | $ | (225 | ) | | $ | (139 | ) | | $ | (118 | ) | | $ | (144 | ) | | | $ | (97 | ) | | | | | | | | $ | (225 | ) | | | $ | (97 | ) | |
| | | | | | | | | | | | | | | | | | |
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment gains (losses) | | | | 359 | | | | (486 | ) | | | (475 | ) | | | (11 | ) | | | | (15 | ) | | | | | | | | | 359 | | | | | (15 | ) | |
Universal life and investment-type product policy fees — amortization of unearned revenue related to investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | (1 | ) | | | 1 | | | | 12 | | | | 8 | | | | | 8 | | | | | | | | | | (1 | ) | | | | 8 | | |
Equity method operating joint ventures realized gains (losses), net of offsets | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Real estate discontinued operations | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Net investment income related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | 106 | | | | | | | | | | — | | | | | 106 | | |
Policyholder benefits and policyholder dividends: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in policyholder dividend obligations related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Changes in asset value fluctuations related to experience-rated contractholder liabilities and certain inflation-indexed liabilities | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Amortization of deferred acquisition costs — related to net investment gains (losses) | | | | — | | | | — | | | | — | | | | — | | | | | — | | | | | | | | | | — | | | | | — | | |
Interest expense — related to consolidated securitization entities | | | | — | | | | — | | | | — | | | | — | | | | | (106 | ) | | | | | | | | | — | | | | | (106 | ) | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Noncontrolling interest | | | | 2 | | | | (12 | ) | | | — | | | | 1 | | | | | 1 | | | | | | | | | | 2 | | | | | 1 | | |
Business combination costs | | | | (11 | ) | | | — | | | | (22 | ) | | | 2 | | | | | (29 | ) | | | | | | | | | (11 | ) | | | | (29 | ) | |
Provision for income tax expense (benefit) | | | | (127 | ) | | | 181 | | | | 168 | | | | 81 | | | | | 12 | | | | | | | | | | (127 | ) | | | | 12 | | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | | (3 | ) | | | (455 | ) | | | (435 | ) | | | (63 | ) | | | | (120 | ) | | | | | | | | | (3 | ) | | | | (120 | ) | |
Income (loss) from discontinued operations, net of income tax | | | | 12 | | | | — | | | | (2 | ) | | | (4 | ) | | | | — | | | | | | | | | | 12 | | | | | — | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | | 9 | | | | (455 | ) | | | (437 | ) | | | (67 | ) | | | | (120 | ) | | | | | | | | | 9 | | | | | (120 | ) | |
Less: Net income (loss) attributable to noncontrolling interest | | | | 1 | | | | (8 | ) | | | — | | | | 1 | | | | | 1 | | | | | | | | | | 1 | | | | | 1 | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | | 8 | | | | (447 | ) | | | (437 | ) | | | (68 | ) | | | | (121 | ) | | | | | | | | | 8 | | | | | (121 | ) | |
Less: Preferred stock dividends | | | | 30 | | | | 31 | | | | 30 | | | | 31 | | | | | 30 | | | | | | | | | | 30 | | | | | 30 | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | (22 | ) | | $ | (478 | ) | | $ | (467 | ) | | $ | (99 | ) | | | $ | (151 | ) | | | | | | | | $ | (22 | ) | | | $ | (151 | ) | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Premiums, Fees and Other Revenues | | | $ | 14 | | | $ | 14 | | | $ | 15 | | | $ | 20 | | | | $ | 22 | | | | | | | | | $ | 14 | | | | $ | 22 | | |
| | | | | | | | | | | | | | | | | | |
35
BANKING, CORPORATE & OTHER — BANKING (1), (2)
SUPPLEMENTAL INFORMATION
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
| | | At or For the Three Months Ended | | | | | | | | At or For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | | | | | | | | March 31, | | | March 31, | |
Unaudited (In millions, except ratios) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | | | | | | | | 2009 | | | 2010 | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The following supplemental information for MetLife Bank is presented in accordance with Banking Standards: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Income Statement | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net interest income, net of interest expense | | | $ | 60 | | | $ | 73 | | | $ | 66 | | | $ | 64 | | | | $ | 58 | | | | | | | | | $ | 60 | | | | $ | 58 | | |
Provision for credit losses | | | | (42 | ) | | | (14 | ) | | | (27 | ) | | | 6 | | | | | (4 | ) | | | | | | | | | (42 | ) | | | | (4 | ) | |
Non interest income | | | | 248 | | | | 275 | | | | 248 | | | | 242 | | | | | 185 | | | | | | | | | | 248 | | | | | 185 | | |
Non interest expense | | | | (203 | ) | | | (231 | ) | | | (181 | ) | | | (220 | ) | | | | (163 | ) | | | | | | | | | (203 | ) | | | | (163 | ) | |
| | | | | | | | | | | | | | | | | | |
Income before taxes | | | | 63 | | | | 103 | | | | 106 | | | | 92 | | | | | 76 | | | | | | | | | | 63 | | | | | 76 | | |
Income tax expense | | | | 22 | | | | 36 | | | | 49 | | | | 35 | | | | | 30 | | | | | | | | | | 22 | | | | | 30 | | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) available to MetLife, Inc.’s common shareholders | | | $ | 41 | | | $ | 67 | | | $ | 57 | | | $ | 57 | | | | $ | 46 | | | | | | | | | $ | 41 | | | | $ | 46 | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Selected Balance Sheet Accounts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Loans Held-for-Investment: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Commercial Loans & Mortgages | | | $ | 2,136 | | | $ | 2,016 | | | $ | 1,965 | | | $ | 2,079 | | | | $ | 2,104 | | | | | | | | | | | | | | | | | |
Consumer | | | | 624 | | | | 724 | | | | 805 | | | | 834 | | | | | 938 | | | | | | | | | | | | | | | | | |
Agriculture | | | | 194 | | | | 185 | | | | 176 | | | | 173 | | | | | 174 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Total Loans | | | | 2,954 | | | | 2,925 | | | | 2,946 | | | | 3,086 | | | | | 3,216 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Allowance for Loan Losses | | | | (74 | ) | | | (87 | ) | | | (101 | ) | | | (93 | ) | | | | (73 | ) | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Total Loans Held-for-Investments (Net) | | | $ | 2,880 | | | $ | 2,838 | | | $ | 2,845 | | | $ | 2,993 | | | | $ | 3,143 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Charge-offs | | | $ | 0.3 | | | $ | 0.5 | | | $ | 12.7 | | | $ | 2.0 | | | | $ | 24.2 | | | | | | | | | $ | 0.3 | | | | $ | 24.2 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Loans Held-for-Sale | | | $ | 3,970 | | | $ | 4,271 | | | $ | 2,442 | | | $ | 2,728 | | | | $ | 2,003 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total Assets | | | $ | 14,816 | | | $ | 14,640 | | | $ | 13,140 | | | $ | 14,107 | | | | $ | 13,573 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total Deposits | | | $ | 7,531 | | | $ | 7,806 | | | $ | 8,372 | | | $ | 10,211 | | | | $ | 10,032 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Key Ratios & Statistics | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Tier 1 Capital | | | $ | 755 | | | $ | 806 | | | $ | 860 | | | $ | 898 | | | | $ | 948 | | | | | | | | | | | | | | | | | |
Risk Weighted Assets | | | $ | 7,270 | | | $ | 7,764 | | | $ | 6,796 | | | $ | 7,381 | | | | $ | 6,909 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Tier 1 Capital Ratio | | | | 10.39 | % | | | 10.39 | % | | | 12.65 | % | | | 12.16 | % | | | | 13.73 | % | | | | | | | | | | | | | | | | |
Total Capital Ratio | | | | 11.40 | % | | | 11.52 | % | | | 13.90 | % | | | 13.41 | % | | | | 14.83 | % | | | | | | | | | | | | | | | | |
Tier 1 Leverage | | | | 6.56 | % | | | 6.22 | % | | | 6.37 | % | | | 6.64 | % | | | | 7.05 | % | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net Interest Margin | | | | 2.12 | % | | | 2.30 | % | | | 2.20 | % | | | 1.98 | % | | | | 1.91 | % | | | | | | | | | 2.12 | % | | | | 1.91 | % | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Allowance / Total Loans | | | | 2.49 | % | | | 2.97 | % | | | 3.44 | % | | | 3.01 | % | | | | 2.27 | % | | | | | | | | | | | | | | | | |
Allowance / Non Performing Assets | | | | 377.55 | % | | | 430.69 | % | | | 135.94 | % | | | 113.00 | % | | | | 162.00 | % | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
(1) | | All amounts on this page relate to MetLife Bank only. |
|
(2) | | Current period numbers are preliminary, subject to regulatory filing on April 30, 2010. |
36
METLIFE, INC.
INVESTMENT RESULTS BY ASSET CATEGORY AND ANNUALIZED YIELDS
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| | | At or For the Three Months Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Fixed Maturity Securities | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | 5.70 | % | | | 5.91 | % | | | 5.89 | % | | | 5.59 | % | | | | 5.73 | % | |
Investment income (2), (3) | | | $ | 2,800 | | | $ | 3,036 | | | $ | 3,090 | | | $ | 2,973 | | | | $ | 3,134 | | |
Investment gains (losses) (3) | | | | (609 | ) | | | (378 | ) | | | (455 | ) | | | (221 | ) | | | | (67 | ) | |
Ending carrying value (2), (3) | | | | 192,337 | | | | 213,034 | | | | 225,866 | | | | 230,026 | | | | | 242,331 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Mortgage Loans | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | 5.32 | % | | | 5.37 | % | | | 5.33 | % | | | 5.50 | % | | | | 5.40 | % | |
Investment income (3), (4) | | | | 680 | | | | 694 | | | | 675 | | | | 686 | | | | | 672 | | |
Investment gains (losses) (3) | | | | (146 | ) | | | (125 | ) | | | (129 | ) | | | (42 | ) | | | | (28 | ) | |
Ending carrying value (3) | | | | 53,044 | | | | 52,500 | | | | 50,681 | | | | 50,909 | | | | | 50,371 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Real Estate and Real Estate Joint Ventures | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | (9.19 | %) | | | (8.83 | %) | | | (6.09 | %) | | | (5.64 | %) | | | | (2.11 | %) | |
Investment income (losses) | | | | (172 | ) | | | (162 | ) | | | (109 | ) | | | (98 | ) | | | | (36 | ) | |
Investment gains (losses) (3) | | | | (25 | ) | | | (68 | ) | | | (70 | ) | | | 7 | | | | | (22 | ) | |
Ending carrying value | | | | 7,381 | | | | 7,296 | | | | 7,032 | | | | 6,896 | | | | | 6,866 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Policy Loans | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | 6.40 | % | | | 6.51 | % | | | 6.56 | % | | | 6.67 | % | | | | 7.04 | % | |
Investment income | | | | 157 | | | | 161 | | | | 163 | | | | 167 | | | | | 178 | | |
Ending carrying value | | | | 9,851 | | | | 9,907 | | | | 10,001 | | | | 10,061 | | | | | 10,146 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Equity Securities | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | 3.92 | % | | | 6.01 | % | | | 4.50 | % | | | 6.13 | % | | | | 3.39 | % | |
Investment income | | | | 37 | | | | 54 | | | | 37 | | | | 47 | | | | | 25 | | |
Investment gains (losses) | | | | (269 | ) | | | (108 | ) | | | (53 | ) | | | 31 | | | | | 27 | | |
Ending carrying value | | | | 2,817 | | | | 3,045 | | | | 3,117 | | | | 3,084 | | | | | 3,066 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Other Limited Partnership Interests | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | (19.79 | %) | | | 5.46 | % | | | 9.75 | % | | | 16.90 | % | | | | 18.85 | % | |
Investment income (losses) | | | | (253 | ) | | | 72 | | | | 127 | | | | 227 | | | | | 265 | | |
Investment gains (losses) | | | | (97 | ) | | | (247 | ) | | | (12 | ) | | | — | | | | | (1 | ) | |
Ending carrying value | | | | 5,365 | | | | 5,193 | | | | 5,255 | | | | 5,508 | | | | | 5,753 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Cash and Short-term Investments | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | 0.48 | % | | | 0.45 | % | | | 0.45 | % | | | 0.34 | % | | | | 0.36 | % | |
Investment income | | | | 36 | | | | 24 | | | | 20 | | | | 14 | | | | | 13 | | |
Investment gains (losses) | | | | (2 | ) | | | 2 | | | | 5 | | | | 1 | | | | | 1 | | |
Ending carrying value (3) | | | | 30,320 | | | | 21,330 | | | | 22,423 | | | | 18,486 | | | | | 17,183 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Other Invested Assets (5) | | | | | | | | | | | | | | | | | | | | | | | |
Investment income | | | | 92 | | | | 98 | | | | 54 | | | | 95 | | | | | 154 | | |
Investment gains (losses) (3) | | | | 233 | | | | (3,033 | ) | | | (1,455 | ) | | | (739 | ) | | | | 101 | | |
Ending carrying value | | | | 15,130 | | | | 13,071 | | | | 13,916 | | | | 12,709 | | | | | 12,327 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Total Investments | | | | | | | | | | | | | | | | | | | | | | | |
Investment income yield (1) | | | | 4.24 | % | | | 5.02 | % | | | 5.14 | % | | | 5.21 | % | | | | 5.53 | % | |
Investment fees and expenses yield | | | | (0.13 | %) | | | (0.15 | %) | | | (0.13 | %) | | | (0.14 | %) | | | | (0.14 | %) | |
| | | | | | | |
Net Investment Income Yield | | | | 4.11 | % | | | 4.87 | % | | | 5.01 | % | | | 5.07 | % | | | | 5.39 | % | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Investment income | | | | 3,377 | | | | 3,977 | | | | 4,057 | | | | 4,111 | | | | | 4,405 | | |
Investment fees and expenses | | | | (103 | ) | | | (118 | ) | | | (101 | ) | | | (111 | ) | | | | (112 | ) | |
| | | | | | | |
Net Investment Income (3) | | | $ | 3,274 | | | $ | 3,859 | | | $ | 3,956 | | | $ | 4,000 | | | | $ | 4,293 | | |
| | | | | | | |
Ending Carrying Value (3) | | | $ | 316,245 | | | $ | 325,376 | | | $ | 338,291 | | | $ | 337,679 | | | | $ | 348,043 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Gross investment gains | | | $ | 571 | | | $ | 263 | | | $ | 299 | | | $ | 416 | | | | $ | 400 | | |
Gross investment losses | | | | (535 | ) | | | (546 | ) | | | (489 | ) | | | (272 | ) | | | | (211 | ) | |
Writedowns | | | | (1,041 | ) | | | (846 | ) | | | (661 | ) | | | (297 | ) | | | | (149 | ) | |
| | | | | | | |
Subtotal | | | | (1,005 | ) | | | (1,129 | ) | | | (851 | ) | | | (153 | ) | | | | 40 | | |
Derivatives gains (losses) | | | | 90 | | | | (2,828 | ) | | | (1,318 | ) | | | (810 | ) | | | | (29 | ) | |
| | | | | | | |
Investment Gains (Losses) (3) | | | | (915 | ) | | | (3,957 | ) | | | (2,169 | ) | | | (963 | ) | | | | 11 | | |
Investment gains (losses) income tax benefit (provision) | | | | 325 | | | | 1,394 | | | | 751 | | | | 406 | | | | | (9 | ) | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Investment Gains (Losses), net of income tax | | | $ | (590 | ) | | $ | (2,563 | ) | | $ | (1,418 | ) | | $ | (557 | ) | | | $ | 2 | | |
| | | | | | | |
(1) | | Yields are based on quarterly average asset carrying values, excluding recognized and unrealized investment gains (losses), and for yield calculation purposes, average of quarterly ending assets exclude collateral received from counterparties associated with the Company’s securities lending program and exclude the effects of consolidating under GAAP certain variable interest entities (“VIEs”) that are treated as consolidated securitization entities. |
|
(2) | | Fixed maturity securities includes $922 million, $1,471 million, $1,970 million, $2,384 million and $2,765 million in ending carrying value, and $17 million, $130 million, $163 million, $90 million and $79 million of investment income (loss) related to trading securities at or for the three months ended March 31, 2009, June 30, 2009, September 30, 2009, December 31, 2009 and March 31, 2010, respectively. |
|
(3) | | Certain measures in this yield table vary from the most directly comparable measures presented in accordance with GAAP. The reconciliation of the yield table measures to the most directly comparable measures presented in accordance with GAAP are: 1) Ending carrying value adjustments for the effects of consolidating under GAAP certain VIEs that are treated as consolidated securitization entities which include trading securities (included within fixed maturity securities in the yield table above) of $274 million, mortgage loans of $7,065 million and cash and short-term investments of $38 million at March 31, 2010; 2) Investment income and net investment income adjustments as presented on page 4 within the Net Income Reconciliation; and 3) Investment gains (losses) presented in the above yield table and GAAP net investment gains (losses) adjustments as presented below for the three months ended: |
| | | | | | | | | | | | | | | | | | | | |
| | March 31, 2009 | | June 30, 2009 | | September 30, 2009 | | December 31, 2009 | | March 31, 2010 |
| | |
Investment gains (losses) — in above yield table | | $ | (915 | ) | | $ | (3,957 | ) | | $ | (2,169 | ) | | $ | (963 | ) | | $ | 11 | |
Real estate discontinued operations | | | — | | | | — | | | | — | | | | (8 | ) | | | — | |
Scheduled periodic settlement payments on derivatives not qualifying for hedge accounting | | | 31 | | | | 32 | | | | (4 | ) | | | 29 | | | | 49 | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivatives not qualifying for hedge accounting | | | (2 | ) | | | — | | | | (1 | ) | | | (1 | ) | | | (3 | ) |
Joint venture earnings related to change in fair value of certain liabilities, including the effects of own credit, associated hedges of these liabilities, and gains and losses from the sales of investments | | | (20 | ) | | | 96 | | | | 35 | | | | 45 | | | | 5 | |
Net investment gains (losses) related to consolidated securitization entities | | | — | | | | — | | | | — | | | | — | | | | 10 | |
| | |
Net investment gains (losses) — GAAP basis | | $ | (906 | ) | | $ | (3,829 | ) | | $ | (2,139 | ) | | $ | (898 | ) | | $ | 72 | |
| | |
(4) | | Investment income from mortgage loans includes prepayment fees. |
|
(5) | | Other invested assets is principally comprised of freestanding derivatives with positive estimated fair values and leveraged leases. Freestanding derivatives with negative estimated fair values are included within other liabilities. However, the accruals of settlement payments in other liabilities are included in net investment income for GAAP. As yield is not considered a meaningful measure of performance for other invested assets, it has been excluded from the yield table. |
37
METLIFE, INC.
INVESTMENT RESULTS BY ASSET CATEGORY AND ANNUALIZED YIELDS
| | | | | | | | | | | | | | | | | | | | | | | |
| | | At or For the Year-to-Date Period Ended | |
| | | March 31, | | June 30, | | September 30, | | December 31, | | | March 31, | |
Unaudited (In millions) | | | 2009 | | 2009 | | 2009 | | 2009 | | | 2010 | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Fixed Maturity Securities | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | 5.70 | % | | | 5.81 | % | | | 5.83 | % | | | 5.77 | % | | | | 5.73 | % | |
Investment income (2), (3) | | | $ | 2,800 | | | $ | 5,836 | | | $ | 8,926 | | | $ | 11,899 | | | | $ | 3,134 | | |
Investment gains (losses) (3) | | | | (609 | ) | | | (987 | ) | | | (1,442 | ) | | | (1,663 | ) | | | | (67 | ) | |
Ending carrying value (2), (3) | | | | 192,337 | | | | 213,034 | | | | 225,866 | | | | 230,026 | | | | | 242,331 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Mortgage Loans | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | 5.32 | % | | | 5.35 | % | | | 5.34 | % | | | 5.38 | % | | | | 5.40 | % | |
Investment income (3), (4) | | | | 680 | | | | 1,374 | | | | 2,049 | | | | 2,735 | | | | | 672 | | |
Investment gains (losses) (3) | | | | (146 | ) | | | (271 | ) | | | (400 | ) | | | (442 | ) | | | | (28 | ) | |
Ending carrying value (3) | | | | 53,044 | | | | 52,500 | | | | 50,681 | | | | 50,909 | | | | | 50,371 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Real Estate and Real Estate Joint Ventures | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | (9.19 | %) | | | (9.01 | %) | | | (8.05 | %) | | | (7.47 | %) | | | | (2.11 | %) | |
Investment income (losses) | | | | (172 | ) | | | (334 | ) | | | (443 | ) | | | (541 | ) | | | | (36 | ) | |
Investment gains (losses) (3) | | | | (25 | ) | | | (93 | ) | | | (163 | ) | | | (156 | ) | | | | (22 | ) | |
Ending carrying value | | | | 7,381 | | | | 7,296 | | | | 7,032 | | | | 6,896 | | | | | 6,866 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Policy Loans | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | 6.40 | % | | | 6.45 | % | | | 6.49 | % | | | 6.54 | % | | | | 7.04 | % | |
Investment income | | | | 157 | | | | 318 | | | | 481 | | | | 648 | | | | | 178 | | |
Ending carrying value | | | | 9,851 | | | | 9,907 | | | | 10,001 | | | | 10,061 | | | | | 10,146 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Equity Securities | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | 3.92 | % | | | 4.94 | % | | | 4.83 | % | | | 5.12 | % | | | | 3.39 | % | |
Investment income | | | | 37 | | | | 91 | | | | 128 | | | | 175 | | | | | 25 | | |
Investment gains (losses) | | | | (269 | ) | | | (377 | ) | | | (430 | ) | | | (399 | ) | | | | 27 | | |
Ending carrying value | | | | 2,817 | | | | 3,045 | | | | 3,117 | | | | 3,084 | | | | | 3,066 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Other Limited Partnership Interests | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | (19.79 | %) | | | (6.59 | %) | | | (1.32 | %) | | | 3.22 | % | | | | 18.85 | % | |
Investment income (losses) | | | | (253 | ) | | | (181 | ) | | | (54 | ) | | | 173 | | | | | 265 | | |
Investment gains (losses) | | | | (97 | ) | | | (344 | ) | | | (356 | ) | | | (356 | ) | | | | (1 | ) | |
Ending carrying value | | | | 5,365 | | | | 5,193 | | | | 5,255 | | | | 5,508 | | | | | 5,753 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Cash and Short-term Investments | | | | | | | | | | | | | | | | | | | | | | | |
Yield (1) | | | | 0.48 | % | | | 0.47 | % | | | 0.46 | % | | | 0.44 | % | | | | 0.36 | % | |
Investment income | | | | 36 | | | | 60 | | | | 80 | | | | 94 | | | | | 13 | | |
Investment gains (losses) | | | | (2 | ) | | | — | | | | 5 | | | | 6 | | | | | 1 | | |
Ending carrying value (3) | | | | 30,320 | | | | 21,330 | | | | 22,423 | | | | 18,486 | | | | | 17,183 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Other Invested Assets (5) | | | | | | | | | | | | | | | | | | | | | | | |
Investment income | | | | 92 | | | | 190 | | | | 244 | | | | 339 | | | | | 154 | | |
Investment gains (losses) (3) | | | | 233 | | | | (2,800 | ) | | | (4,255 | ) | | | (4,994 | ) | | | | 101 | | |
Ending carrying value | | | | 15,130 | | | | 13,071 | | | | 13,916 | | | | 12,709 | | | | | 12,327 | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Total Investments | | | | | | | | | | | | | | | | | | | | | | | |
Investment income yield (1) | | | | 4.24 | % | | | 4.63 | % | | | 4.80 | % | | | 4.90 | % | | | | 5.53 | % | |
Investment fees and expenses yield | | | | (0.13 | %) | | | (0.14 | %) | | | (0.14 | %) | | | (0.14 | %) | | | | (0.14 | %) | |
| | | | | | | |
Net Investment Income Yield | | | | 4.11 | % | | | 4.49 | % | | | 4.66 | % | | | 4.76 | % | | | | 5.39 | % | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Investment income | | | | 3,377 | | | | 7,354 | | | | 11,411 | | | | 15,522 | | | | | 4,405 | | |
Investment fees and expenses | | | | (103 | ) | | | (221 | ) | | | (322 | ) | | | (433 | ) | | | | (112 | ) | |
| | | | | | | |
Net Investment Income (3) | | | $ | 3,274 | | | $ | 7,133 | | | $ | 11,089 | | | $ | 15,089 | | | | $ | 4,293 | | |
| | | | | | | |
Ending Carrying Value (3) | | | $ | 316,245 | | | $ | 325,376 | | | $ | 338,291 | | | $ | 337,679 | | | | $ | 348,043 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Gross investment gains | | | $ | 571 | | | $ | 834 | | | $ | 1,133 | | | $ | 1,549 | | | | $ | 400 | | |
Gross investment losses | | | | (535 | ) | | | (1,081 | ) | | | (1,570 | ) | | | (1,842 | ) | | | | (211 | ) | |
Writedowns | | | | (1,041 | ) | | | (1,887 | ) | | | (2,548 | ) | | | (2,845 | ) | | | | (149 | ) | |
| | | | | | | |
Subtotal | | | | (1,005 | ) | | | (2,134 | ) | | | (2,985 | ) | | | (3,138 | ) | | | | 40 | | |
Derivatives gains (losses) | | | | 90 | | | | (2,738 | ) | | | (4,056 | ) | | | (4,866 | ) | | | | (29 | ) | |
| | | | | | | |
Investment Gains (Losses) (3) | | | | (915 | ) | | | (4,872 | ) | | | (7,041 | ) | | | (8,004 | ) | | | | 11 | | |
Investment gains (losses) income tax benefit (provision) | | | | 325 | | | | 1,719 | | | | 2,470 | | | | 2,876 | | | | | (9 | ) | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Investment Gains (Losses), net of income tax | | | $ | (590 | ) | | $ | (3,153 | ) | | $ | (4,571 | ) | | $ | (5,128 | ) | | | $ | 2 | | |
| | | | | | | |
(1) | | Yields are based on average of quarterly asset carrying values, excluding recognized and unrealized investment gains (losses), and for yield calculation purposes, average of quarterly ending assets exclude collateral received from counterparties associated with the Company’s securities lending program and exclude the effects of consolidating under GAAP certain VIEs that are treated as consolidated securitization entities. |
|
(2) | | Fixed maturity securities includes $922 million, $1,471 million, $1,970 million, $2,384 million and $2,765 million in ending carrying value, and $17 million, $147 million, $310 million, $400 million and $79 million of investment income (loss) related to trading securities at or for the year-to-date period ended March 31, 2009, June 30, 2009, September 30, 2009, December 31, 2009 and March 31, 2010, respectively. |
|
(3) | | Certain measures in this yield table vary from the most directly comparable measures presented in accordance with GAAP. The reconciliation of the yield table measures to the most directly comparable measures presented in accordance with GAAP are: 1) Ending carrying value adjustments for the effects of consolidating under GAAP certain VIEs that are treated as consolidated securitization entities which include trading securities (included within fixed maturity securities in the yield table above) of $274 million, mortgage loans of $7,065 million and cash and short-term investments of $38 million at March 31, 2010; 2) Investment income and net investment income adjustments as presented on page 4 within the Net Income Reconciliation; and 3) Investment gains (losses) presented in the above yield table and GAAP net investment gains (losses) adjustments as presented below for the year-to-date periods ended: |
| | | | | | | | | | | | | | | | | | | | |
| | March 31, 2009 | | June 30, 2009 | | September 30, 2009 | | December 31, 2009 | | March 31, 2010 |
| | |
Investment gains (losses) — in above yield table | | $ | (915 | ) | | $ | (4,872 | ) | | $ | (7,041 | ) | | $ | (8,004 | ) | | $ | 11 | |
Real estate discontinued operations | | | — | | | | — | | | | — | | | | (8 | ) | | | — | |
Scheduled periodic settlement payments on derivatives not qualifying for hedge accounting | | | 31 | | | | 63 | | | | 59 | | | | 88 | | | | 49 | |
Interest credited to policyholder account balances — scheduled periodic settlement payments on derivatives not qualifying for hedge accounting | | | (2 | ) | | | (2 | ) | | | (3 | ) | | | (4 | ) | | | (3 | ) |
Joint venture earnings related to change in fair value of certain liabilities, including the effects of own credit, associated hedges of these liabilities, and gains and losses from the sales of investments | | | (20 | ) | | | 76 | | | | 111 | | | | 156 | | | | 5 | |
Net investment gains (losses) related to consolidated securitization entities | | | — | | | | — | | | | — | | | | — | | | | 10 | |
| | |
Net investment gains (losses) — GAAP basis | | $ | (906 | ) | | $ | (4,735 | ) | | $ | (6,874 | ) | | $ | (7,772 | ) | | $ | 72 | |
| | |
(4) | | Investment income from mortgage loans includes prepayment fees. |
|
(5) | | Other invested assets is principally comprised of freestanding derivatives with positive estimated fair values and leveraged leases. Freestanding derivatives with negative estimated fair values are included within other liabilities. However, the accruals of settlement payments in other liabilities are included in net investment income for GAAP. As yield is not considered a meaningful measure of performance for other invested assets, it has been excluded from the yield table. |
38
METLIFE, INC.
GROSS UNREALIZED GAINS AND LOSSES AGING SCHEDULE
FIXED MATURITY SECURITIES AVAILABLE-FOR-SALE (1)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | March 31, 2009 | | | June 30, 2009 | | | September 30, 2009 | | | December 31, 2009 | | | | March 31, 2010 | | |
Unaudited (In millions) | | | Amount | | | % of Total | | | Amount | | | % of Total | | | Amount | | | % of Total | | | Amount | | | % of Total | | | | Amount | | | % of Total | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Less than 20% | | | $ | 6,951 | | | | 24.2 | % | | $ | 6,220 | | | | 31.9 | % | | $ | 4,050 | | | | 35.4 | % | | $ | 4,815 | | | | 45.9 | % | | | $ | 4,244 | | | | 51.4 | % | |
20% or more for less than six months | | | | 12,494 | | | | 43.4 | % | | | 1,973 | | | | 10.1 | % | | | 540 | | | | 4.7 | % | | | 713 | | | | 6.8 | % | | | | 480 | | | | 5.8 | % | |
20% or more for six months or greater | | | | 9,312 | | | | 32.4 | % | | | 11,320 | | | | 58.0 | % | | | 6,850 | | | | 59.9 | % | | | 4,958 | | | | 47.3 | % | | | | 3,528 | | | | 42.8 | % | |
| | | | | | | |
Total Gross Unrealized Losses | | | $ | 28,757 | | | | 100.0 | % | | $ | 19,513 | | | | 100.0 | % | | $ | 11,440 | | | | 100.0 | % | | $ | 10,486 | | | | 100.0 | % | | | $ | 8,252 | | | | 100.0 | % | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total Gross Unrealized Gains | | | $ | 5,562 | | | | | | | $ | 5,582 | | | | | | | $ | 10,062 | | | | | | | $ | 8,419 | | | | | | | | $ | 9,757 | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
GROSS UNREALIZED GAINS AND LOSSES AGING SCHEDULE EQUITY SECURITIES AVAILABLE-FOR-SALE (1) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | March 31, 2009 | | | June 30, 2009 | | | September 30, 2009 | | | December 31, 2009 | | | | March 31, 2010 | | |
Unaudited (In millions) | | | Amount | | | % of Total | | | Amount | | | % of Total | | | Amount | | | % of Total | | | Amount | | | % of Total | | | | Amount | | | % of Total | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Less than 20% | | | $ | 25 | | | | 2.1 | % | | $ | 26 | | | | 3.6 | % | | $ | 85 | | | | 21.3 | % | | $ | 83 | | | | 30.2 | % | | | $ | 84 | | | | 34.0 | % | |
20% or more for less than six months | | | | 490 | | | | 40.8 | % | | | 143 | | | | 19.8 | % | | | 13 | | | | 3.3 | % | | | 14 | | | | 5.1 | % | | | | 35 | | | | 14.2 | % | |
20% or more for six months or greater | | | | 687 | | | | 57.1 | % | | | 552 | | | | 76.6 | % | | | 300 | | | | 75.4 | % | | | 178 | | | | 64.7 | % | | | | 128 | | | | 51.8 | % | |
| | | | | | | |
Total Gross Unrealized Losses | | | $ | 1,202 | | | | 100.0 | % | | $ | 721 | | | | 100.0 | % | | $ | 398 | | | | 100.0 | % | | $ | 275 | | | | 100.0 | % | | | $ | 247 | | | | 100.0 | % | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total Gross Unrealized Gains | | | $ | 32 | | | | | | | $ | 87 | | | | | | | $ | 166 | | | | | | | $ | 172 | | | | | | | | $ | 208 | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| | |
(1) | | The Company’s review of its fixed maturity securities and equity securities for impairments includes an analysis of the total gross unrealized losses by three categories of securities: (i) securities where the estimated fair value had declined and remained below cost or amortized cost by less than 20%; (ii) securities where the estimated fair value had declined and remained below cost or amortized cost by 20% or more for less than six months; and (iii) securities where the estimated fair value had declined and remained below cost or amortized cost by 20% or more for six months or greater. |
39
METLIFE, INC.
SUMMARY OF FIXED MATURITY SECURITIES AVAILABLE-FOR-SALE
BY SECTOR AND QUALITY DISTRIBUTION
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| | | March 31, 2009 | | June 30, 2009 | | September 30, 2009 | | December 31, 2009 | | | March 31, 2010 | |
Unaudited (In millions) | | | Amount | | % of Total | | Amount | | % of Total | | Amount | | % of Total | | Amount | | % of Total | | | Amount | | % of Total | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
U.S. corporate securities | | | $ | 60,714 | | | | 31.7 | % | | $ | 65,981 | | | | 31.2 | % | | $ | 71,642 | | | | 32.1 | % | | $ | 72,187 | | | | 31.7 | % | | | $ | 74,133 | | | | 31.0 | % | |
Residential mortgage-backed securities | | | | 38,115 | | | | 19.9 | % | | | 41,798 | | | | 19.8 | % | | | 43,397 | | | | 19.4 | % | | | 44,020 | | | | 19.3 | % | | | | 42,980 | | | | 17.9 | % | |
Foreign corporate securities | | | | 29,405 | | | | 15.4 | % | | | 33,607 | | | | 15.9 | % | | | 36,592 | | | | 16.3 | % | | | 38,030 | | | | 16.7 | % | | | | 40,105 | | | | 16.7 | % | |
U.S. Treasury, agency and government guaranteed securities | | | | 24,649 | | | | 12.9 | % | | | 27,673 | | | | 13.1 | % | | | 25,467 | | | | 11.4 | % | | | 25,447 | | | | 11.2 | % | | | | 30,741 | | | | 12.8 | % | |
Commercial mortgage-backed securities | | | | 12,981 | | | | 6.8 | % | | | 13,995 | | | | 6.6 | % | | | 15,535 | | | | 6.9 | % | | | 15,622 | | | | 6.9 | % | | | | 16,495 | | | | 6.9 | % | |
Asset-backed securities | | | | 11,032 | | | | 5.7 | % | | | 12,414 | | | | 5.8 | % | | | 13,251 | | | | 5.9 | % | | | 13,162 | | | | 5.8 | % | | | | 13,892 | | | | 5.8 | % | |
Foreign government securities | | | | 9,384 | | | | 4.9 | % | | | 10,560 | | | | 5.0 | % | | | 11,447 | | | | 5.1 | % | | | 11,947 | | | | 5.2 | % | | | | 13,164 | | | | 5.5 | % | |
State and political subdivision securities | | | | 5,112 | | | | 2.7 | % | | | 5,517 | | | | 2.6 | % | | | 6,549 | | | | 2.9 | % | | | 7,208 | | | | 3.2 | % | | | | 8,039 | | | | 3.4 | % | |
Other fixed maturity securities | | | | 23 | | | | 0.0 | % | | | 18 | | | | 0.0 | % | | | 16 | | | | 0.0 | % | | | 19 | | | | 0.0 | % | | | | 17 | | | | 0.0 | % | |
| | | | | | | |
Total fixed maturity securities available-for-sale | | | $ | 191,415 | | | | 100.0 | % | | $ | 211,563 | | | | 100.0 | % | | $ | 223,896 | | | | 100.0 | % | | $ | 227,642 | | | | 100.0 | % | | | $ | 239,566 | | | | 100.0 | % | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
NAIC RATING RATING AGENCY DESIGNATION | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | (1 | ) | | | | | | | (1 | ) | | | | | | | (1 | ) | | | | | | | (2 | ) | | | | | | | | (2 | ) | | | | | |
| | | | | | | | | | | | | |
1 Aaa / Aa / A | | | $ | 137,190 | | | | 71.7 | % | | $ | 147,337 | | | | 69.6 | % | | $ | 153,893 | | | | 68.7 | % | | $ | 151,136 | | | | 66.4 | % | | | $ | 160,030 | | | | 66.8 | % | |
2 Baa | | | | 39,346 | | | | 20.6 | % | | | 45,949 | | | | 21.7 | % | | | 48,612 | | | | 21.7 | % | | | 56,305 | | | | 24.7 | % | | | | 59,061 | | | | 24.6 | % | |
3 Ba | | | | 8,697 | | | | 4.5 | % | | | 9,598 | | | | 4.6 | % | | | 9,860 | | | | 4.4 | % | | | 12,003 | | | | 5.3 | % | | | | 12,105 | | | | 5.1 | % | |
4 B | | | | 4,368 | | | | 2.3 | % | | | 5,717 | | | | 2.7 | % | | | 5,927 | | | | 2.7 | % | | | 6,461 | | | | 2.9 | % | | | | 6,937 | | | | 2.9 | % | |
5 Caa and lower | | | | 1,734 | | | | 0.9 | % | | | 2,756 | �� | | | 1.3 | % | | | 5,330 | | | | 2.4 | % | | | 1,425 | | | | 0.6 | % | | | | 1,282 | | | | 0.5 | % | |
6 In or near default | | | | 80 | | | | 0.0 | % | | | 206 | | | | 0.1 | % | | | 274 | | | | 0.1 | % | | | 312 | | | | 0.1 | % | | | | 151 | | | | 0.1 | % | |
| | | | | | | |
Total fixed maturity securities available-for-sale | | | $ | 191,415 | | | | 100.0 | % | | $ | 211,563 | | | | 100.0 | % | | $ | 223,896 | | | | 100.0 | % | | $ | 227,642 | | | | 100.0 | % | | | $ | 239,566 | | | | 100.0 | % | |
| | | | | | | |
| | |
(1) | | Amounts presented are based on rating agency designations and equivalent ratings of the National Association of Insurance Commissioners (“NAIC”). The rating agency designations are based on availability of applicable ratings from those rating agencies on the NAIC acceptable rating organizations list. |
|
(2) | | Amounts presented are based on rating agency designations and equivalent ratings of the NAIC, with the exception of non-agency residential mortgage-backed securities held by the Company’s domestic insurance subsidiaries. Amounts presented for non-agency residential mortgage-backed securities held by the Company’s domestic insurance subsidiaries are based on final ratings from the revised NAIC rating methodology which became effective December 31, 2009 which may not correspond to the rating agency designations. Specifically, certain non-agency residential mortgage-backed securities rated Caa and lower and in or near default based on rating agency designations are presented at December 31, 2009 with their final NAIC rating ranging from NAIC 1 to NAIC 4 based on the revised NAIC rating methodology effective December 31, 2009. |
SUMMARY OF COMMERCIAL MORTGAGE LOANS
BY REGION AND PROPERTY TYPE
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| | | March 31, 2009 | | June 30, 2009 | | September 30, 2009 | | December 31, 2009 | | | March 31, 2010 | |
Unaudited (In millions) | | | Amount | | % of Total | | Amount | | % of Total | | Amount | | % of Total | | Amount | | % of Total | | | Amount | | % of Total | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Pacific | | | $ | 8,757 | | | | 24.4 | % | | $ | 8,679 | | | | 24.8 | % | | $ | 8,806 | | | | 25.3 | % | | $ | 8,684 | | | | 25.1 | % | | | $ | 8,497 | | | | 24.5 | % | |
South Atlantic | | | | 8,064 | | | | 22.5 | % | | | 7,627 | | | | 21.8 | % | | | 7,454 | | | | 21.4 | % | | | 7,342 | | | | 21.2 | % | | | | 7,426 | | | | 21.4 | % | |
Middle Atlantic | | | | 6,129 | | | | 17.1 | % | | | 5,879 | | | | 16.8 | % | | | 5,639 | | | | 16.2 | % | | | 5,948 | | | | 17.2 | % | | | | 6,075 | | | | 17.4 | % | |
International | | | | 3,350 | | | | 9.3 | % | | | 3,461 | | | | 9.9 | % | | | 3,590 | | | | 10.3 | % | | | 3,564 | | | | 10.3 | % | | | | 3,676 | | | | 10.6 | % | |
West South Central | | | | 3,006 | | | | 8.4 | % | | | 2,908 | | | | 8.3 | % | | | 2,906 | | | | 8.3 | % | | | 2,870 | | | | 8.3 | % | | | | 2,868 | | | | 8.3 | % | |
East North Central | | | | 2,580 | | | | 7.2 | % | | | 2,561 | | | | 7.3 | % | | | 2,545 | | | | 7.3 | % | | | 2,487 | | | | 7.2 | % | | | | 2,513 | | | | 7.2 | % | |
New England | | | | 1,517 | | | | 4.2 | % | | | 1,465 | | | | 4.2 | % | | | 1,451 | | | | 4.2 | % | | | 1,414 | | | | 4.1 | % | | | | 1,394 | | | | 4.0 | % | |
Mountain | | | | 1,049 | | | | 2.9 | % | | | 1,044 | | | | 3.0 | % | | | 1,039 | | | | 3.0 | % | | | 944 | | | | 2.7 | % | | | | 928 | | | | 2.7 | % | |
West North Central | | | | 682 | | | | 1.9 | % | | | 677 | | | | 1.9 | % | | | 667 | | | | 2.0 | % | | | 641 | | | | 1.9 | % | | | | 632 | | | | 1.8 | % | |
East South Central | | | | 465 | | | | 1.4 | % | | | 462 | | | | 1.3 | % | | | 460 | | | | 1.3 | % | | | 443 | | | | 1.3 | % | | | | 441 | | | | 1.3 | % | |
Other | | | | 254 | | | | 0.7 | % | | | 254 | | | | 0.7 | % | | | 253 | | | | 0.7 | % | | | 250 | | | | 0.7 | % | | | | 277 | | | | 0.8 | % | |
| | | | | | | |
Total | | | $ | 35,853 | | | | 100.0 | % | | $ | 35,017 | | | | 100.0 | % | | $ | 34,810 | | | | 100.0 | % | | $ | 34,587 | | | | 100.0 | % | | | $ | 34,727 | | | | 100.0 | % | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Office | | | $ | 15,215 | | | | 42.4 | % | | $ | 14,832 | | | | 42.3 | % | | $ | 14,988 | | | | 43.1 | % | | $ | 14,986 | | | | 43.3 | % | | | $ | 15,046 | | | | 43.3 | % | |
Retail | | | | 8,002 | | | | 22.3 | % | | | 7,941 | | | | 22.7 | % | | | 8,081 | | | | 23.2 | % | | | 7,870 | | | | 22.8 | % | | | | 8,032 | | | | 23.1 | % | |
Apartments | | | | 4,062 | | | | 11.3 | % | | | 3,838 | | | | 11.0 | % | | | 3,725 | | | | 10.7 | % | | | 3,696 | | | | 10.7 | % | | | | 3,656 | | | | 10.6 | % | |
Hotel | | | | 3,058 | | | | 8.6 | % | | | 3,076 | | | | 8.8 | % | | | 2,967 | | | | 8.5 | % | | | 2,947 | | | | 8.5 | % | | | | 2,946 | | | | 8.5 | % | |
Industrial | | | | 2,818 | | | | 7.9 | % | | | 2,802 | | | | 8.0 | % | | | 2,804 | | | | 8.1 | % | | | 2,759 | | | | 8.0 | % | | | | 2,776 | | | | 8.0 | % | |
Other | | | | 2,698 | | | | 7.5 | % | | | 2,528 | | | | 7.2 | % | | | 2,245 | | | | 6.4 | % | | | 2,329 | | | | 6.7 | % | | | | 2,271 | | | | 6.5 | % | |
| | | | | | | |
Total | | | $ | 35,853 | | | | 100.0 | % | | $ | 35,017 | | | | 100.0 | % | | $ | 34,810 | | | | 100.0 | % | | $ | 34,587 | | | | 100.0 | % | | | $ | 34,727 | | | | 100.0 | % | |
| | | | | | | |
40
METLIFE, INC.
SUMMARY OF REAL ESTATE AND REAL ESTATE JOINT VENTURES
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| | | March 31, | | | June 30, | | | September 30, | | | December 31, | | | | March 31, | | |
Unaudited (In millions) | | | 2009 | | | 2009 | | | 2009 | | | 2009 | | | | 2010 | | |
| | | | | | | |
Wholly-owned | | | $ | 4,059 | | | $ | 4,069 | | | $ | 4,061 | | | $ | 4,071 | | | | $ | 4,079 | | |
Joint ventures | | | | 3,319 | | | | 3,141 | | | | 2,846 | | | | 2,698 | | | | | 2,651 | | |
Subtotal | | | | 7,378 | | | | 7,210 | | | | 6,907 | | | | 6,769 | | | | | 6,730 | | |
Foreclosed | | | | 3 | | | | 86 | | | | 125 | | | | 127 | | | | | 136 | | |
| | | | | | | |
Total Real Estate and Real Estate Joint Ventures (1) | | | $ | 7,381 | | | $ | 7,296 | | | $ | 7,032 | | | $ | 6,896 | | | | $ | 6,866 | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
SUMMARY OF MORTGAGE LOANS | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| | | March 31, | | | June 30, | | | September 30, | | | December 31, | | | | March 31, | | |
Unaudited (In millions) | | | 2009 | | | 2009 | | | 2009 | | | 2009 | | | | 2010 | | |
| | | | | | | |
Commercial mortgage loans | | | $ | 35,853 | | | $ | 35,017 | | | $ | 34,810 | | | $ | 34,587 | | | | $ | 34,727 | | |
Agricultural mortgage loans | | | | 12,066 | | | | 11,913 | | | | 12,059 | | | | 12,140 | | | | | 12,093 | | |
Residential and consumer loans | | | | 1,155 | | | | 1,299 | | | | 1,370 | | | | 1,454 | | | | | 1,548 | | |
Mortgage loans held-for-sale | | | | 3,970 | | | | 4,271 | | | | 2,442 | | | | 2,728 | | | | | 2,003 | | |
| | | | | | | |
Total (2) | | | $ | 53,044 | | | $ | 52,500 | | | $ | 50,681 | | | $ | 50,909 | | | | $ | 50,371 | | |
| | | | | | | |
| | |
(1) | | Includes real estate held-for-sale and held-for-investment. |
|
(2) | | Effective January 1, 2010, balance excludes the effects of consolidating under GAAP certain variable interest entities that are treated as consolidated securitization entities. See page 37, note 3 for the amount excluded at March 31, 2010. |
41
Company Ratings as of April 28, 2010
Insurer financial strength ratings represent the opinions of rating agencies, including A.M. Best Company (“A.M. Best”), Fitch Ratings Insurance Group (“Fitch”), Moody’s Investors Service (“Moody’s”) and Standard & Poor’s (“S&P”), regarding the ability of an insurance company to meet its financial obligations to policyholders and contractholders. Credit ratings represent the opinions of rating agencies regarding an issuer’s ability to repay its indebtedness. Our insurer financial strength ratings and credit ratings as of April 28, 2010 are listed in the tables below:
| | | | | | | | |
| | A.M. Best* | | Fitch* | | Moody’s* | | S&P* |
Insurer Financial Strength Ratings | | | | | | | | |
| | | | | | | | |
First MetLife Investors Insurance Co. | | A+ | | NR | | NR | | AA- |
General American Life Insurance Company | | A+ | | AA- | | Aa3 | | AA- |
MetLife Insurance Company of Connecticut | | A+ | | AA- | | Aa3 | | AA- |
MetLife Investors Insurance Company | | A+ | | AA- | | Aa3 | | AA- |
MetLife Investors USA Insurance Company | | A+ | | AA- | | Aa3 | | AA- |
Metropolitan Casualty Insurance Company | | A | | NR | | NR | | NR |
Metropolitan Direct Property and Casualty Insurance Co. | | A | | NR | | NR | | NR |
Metropolitan General Insurance Company | | A | | NR | | NR | | NR |
Metropolitan Group Property & Casualty Insurance Co. | | A | | NR | | NR | | NR |
Metropolitan Life Insurance Company | | A+ | | AA- | | Aa3 | | AA- |
Metropolitan Lloyds Insurance Company of Texas | | A | | NR | | NR | | NR |
Metropolitan Property and Casualty Insurance Company | | A | | NR | | NR | | NR |
Metropolitan Tower Life Insurance Company | | A+ | | NR | | Aa3 | | NR |
New England Life Insurance Company | | A+ | | AA- | | Aa3 | | AA- |
| | | | | | | | |
Credit Ratings | | | | | | | | |
MetLife Short Term Funding LLC | | | | | | | | |
Commercial Paper | | NR | | NR | | P-1 | | A-1+ |
| | | | | | | | |
General American Life Insurance Company | | | | | | | | |
(Surplus Notes) | | a | | NR | | A2 | | A |
| | | | | | | | |
MetLife, Inc. | | | | | | | | |
Commercial Paper | | AMB-1 | | F1 | | P-2 | | A-2 |
Senior Unsecured Debt | | a- | | A- | | A3 | | A- |
Subordinated Debt | | bbb+ | | NR | | Baa1 | | NR |
Junior Subordinated Debt | | bbb | | BBB | | Baa2 | | BBB |
Preferred Stock | | bbb | | NR | | Baa2 | | BBB |
Non-Cumulative Perpetual Preferred Stock | | bbb | | BBB | | Baa2 | | BBB- |
| | | | | | | | |
MetLife Capital Trust IV & X | | | | | | | | |
Trust Securities | | bbb | | BBB | | Baa2 | | BBB |
| | | | | | | | |
MetLife Funding, Inc. | | | | | | | | |
Commercial Paper | | AMB-1+ | | F1+ | | P-1 | | A-1+ |
| | | | | | | | |
Metropolitan Life Global Funding I | | | | | | | | |
Senior Secured Debt | | aa- | | NR | | Aa3 | | AA- |
| | | | | | | | |
MetLife Institutional Funding I, LLC | | | | | | | | |
Senior Secured Debt | | aa- | | NR | | Aa3 | | AA- |
| | | | | | | | |
Metropolitan Life Insurance Company | | | | | | | | |
Surplus Notes | | a | | A | | A2 | | A |
| | |
* | | Ratings outlooks are “Under review with negative implications, Stable, Negative, CreditWatch negative” for A.M. Best, Fitch, Moody’s and S&P, respectively. |
|
NR | | Not Rated |
42